Podcasts about endovascular surgery

In this episode, Audible Bleeding Editors Sasank Kalipatnapu (@ksasank), Falen Demsas sit down with Dr. Rabih Chaer (@rchaer2), Dr. Michael Conte(@MichaelSConteMD), Dr. Sherene Shalhub and Dr. Malachi Sheahan III, the four SVS secretary candidates for this year to learn more about them as part of the ongoing election process.    Show links: SVS 2025 Meet the Secretary Candidates—Home Page—provides a comprehensive overview of all the candidates. Their professional biographies and answers to questions about their plans for the future are available in both text and video formats.   Show Guests: Dr. Rabih Chaer, Professor of Surgery and Chief of the Division of Vascular Surgery at Stony Brook University Dr. Michael Conte, Professor and Chief of the Division of Vascular & Endovascular Surgery at the University of California, San Francisco. Dr. Sherene Shalhub, Professor and Chief of the Division Vascular and Endovascular Surgery at Oregon Health & Science University (OHSU). Dr. Malachi Sheahan, Professor and Chair of the Division of Vascular and Endovascular Surgery at Louisiana State University Health Sciences Center in New Orleans. Sasank Kalipatnapu - PGY4 general surgery resident, University of Massachusetts Falen Demsas- PGY 3 integrated vascular surgery resident, Massachusetts General Hospital    Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

In this episode, Audible Bleeding Editors Sasank Kalipatnapu (@ksasank), Richa Kalsi (@KalsiMD) sit down with Dr. Andres Schanzer and Dr. William Shutze, the two SVS vice presidential candidates for this year to learn more about them as part of the ongoing election process.    Show links: SVS 2025 Meet the VP Candidates provides a comprehensive overview of all the candidates. Their professional biographies and answers to questions about their plans for the future are available in both text and video formats.   Show Guests: Dr. Andres Schanzer, Professor and Chief in the Division of Vascular and Endovascular Surgery, UMass Medical School, Worcester, MA Dr. William P Shutze, Texas Vascular Associates, Plano TX    Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

Dr. Ezra Schwartz (@ezraschwartz10) interviews Dr. Firas Moussa and Mr. Jake Howitt to discuss the IMPROVE-AD Trial, a landmark, multi-institutional study investigating treatment strategies for uncomplicated Type B Aortic Dissection (uTBAD). The IMPROVE-AD Trial is a multicenter randomized trial funded by the NIH/NHLBI that compares thoracic endovascular aortic repair (TEVAR) plus optimal medical therapy (OMT) vs. OMT and surveillance with selective TEVAR in patients with uncomplicated TBAD. The trial aims to address critical gaps in evidence left by prior studies (INSTEAD-XL, ADSORB), with a unique focus on quality of life, cost-effectiveness, and genetic data. Dr. Firas Mussa is a professor and the Chief of Vascular and Endovascular Surgery at McGovern Medical School at UTHealth Houston. He previously served as the Director of the Vascular Surgery Residency and Fellowship programs at NYU Langone Health. Dr. Mussa earned his medical degree from the University of Baghdad, followed by general surgery training at Johns Hopkins University and a vascular surgery fellowship at Baylor College of Medicine. His research focuses on complex aortic pathology, and he serves as the principal investigator of the IMPROVE AD trial. Mr. Jake Howitt is the Community Engagement Co-Chair of the IMPROVE AD trial and a leading patient advocate within the PCORI-funded Aortic Dissection Collaborative. As a survivor of aortic dissection, he is passionate about improving patient-provider communication and raising awareness of hereditary aortic disease. His work emphasizes the importance of education, empathy, and community-building in clinical research and care delivery. Special thank you to Jacob Soucy (@JacobWSoucy). Resources: ·       Treatment of Uncomplicated Type B Aortic Dissection: Optimal Medical Therapy vs TEVAR + Optimal Medical Therapy- https://journals.sagepub.com/doi/10.1177/15385744231184671?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed  ·       INSTEAD Trial - https://pubmed.ncbi.nlm.nih.gov/19996018/ ·       INSTEAD-XL 5-Year Follow-Up - https://pubmed.ncbi.nlm.nih.gov/23922146/ ·       ADSORB Trial - https://pubmed.ncbi.nlm.nih.gov/24962744/ ·       Feasibility of a proposed randomized trial in patients with uncomplicated descending thoracic aortic dissection: Results of worldwide survey - https://pubmed.ncbi.nlm.nih.gov/27823685/ ·       Treatment of AD: Meta-Analysis - https://pubmed.ncbi.nlm.nih.gov/29066151/ ·       TEVAR vs Medical Therapy- https://pubmed.ncbi.nlm.nih.gov/36334259/ ·       IMPROVE AD Trial website - https://improvead.org ·       John Ritter Foundation for Aortic Health - https://johnritterfoundation.org ·       Think Aorta US - https://thinkaorta.us   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.      

Audible Bleeding editor Wen (@WenKawaji) is joined by first year vascular fellow Eva (@urrechisme), second year vascular fellow Java (@JabbariMD), JVS editor Dr. Forbes (@TL_Forbes), and JVS-VS associate editor Dr. Hedin to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Ann Gaffey, Dr. Mohammed Hamouda, and Dr. Young Erben, the authors of the following papers.    Articles:   Outcomes of Prosthetic and Biological Grafts Compared to Arm Vein Grafts in Patients with Chronic Limb Threatening Ischemia Proteomic Analysis of Carotid Artery Plaques With and Without Vulnerable Features on MRI with Vessel Wall Imaging: A pilot study    Show Guests  Dr. Ann Gaffey (@Ann_Gaffey_MD): Assistant professor of surgery at UC San Diego School of Medicine in the Division of Vascular and Endovascular Surgery. Dr. Gaffey's clinical interests include examining new approaches to peripheral arterial disease and improving the patency of current bypass options.  Dr. Mohammed Hamouda (@hamouda_mmz): Postdoctoral research fellow at UC San Diego, Division of Vascular & Endovascular Surgery Dr. Young Erben (@ErbenYoung): vascular surgeon from Mayo Clinic in Jacksonville Florida. She earned her medical degree from Goethe University in Frankfurt, Germany, and completed her general surgery as well as vascular surgery training at the Mayo Clinic in Rochester, Minnesota. Her clinical interests include cerebrovascular, aortic, and peripheral pathologies, as well as initiatives to eradicate disparities in care. Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

Join us for this week's Editor's Choice Article about ‘Machine Learning Based Prediction of Post-operative Infrarenal Endograft Apposition for Abdominal Aortic Aneurysms' (Nov 2024 EJVES). We are honoured to have the first author Dr. van Veldhuizen join us for an in depth discussion of the paper, explaining the intricacies of the model and what this research could mean for future automated preoperative aortic planning. Link to full article:Machine Learning-Based Prediction of Post-operative Infrarenal Endograft Apposition for Abdominal Aortic AneurysmsWillemina van Veldhuizen, Jean-Paul P.M. de Vries, Annemarii Tuinstra, Jelmer M. Wolterink, Richte. C.L. Schuurmann, Virtual Stenting Study Group. European Journal of Vascular and Endovascular Surgery. November 2024. 68(5):577-578.Unlocking Endoleak Risk: Machine Learning and Aortic Geometry in Endovascular Aneurysm Repair Failure Prediction Ryan Gouveia E Melo, Graeme K Ambler European Journal of Vascular and Endovascular Surgery November 2024. Volume 68, Issue 5, P577-578.Link to full article: https://linkinghub.elsevier.com/retrieve/pii/S1078-5884(24)00685-3Shortest Apposition Length at the First Postoperative Computed Tomography Angiography Identifies Patients at Risk for Developing a Late Type la Endoleak, After Endovascular Aneurysm Repair. Anna C.M. Geraedts, MD, Roy Zuidema, MD. ODYSSEUS-TIEL Study Group. Volume 31, Issue 2. Journal of Endovascular Therapy. Volume 31, Issue 2, April 2024. Pages 274-281.Link to full article: https://doi.org/10.1177/15266028221120514Use of Artificial Intelligence With Deep Learning Approaches for the Follow-up of Infrarenal Endovascular Aortic Repair. Quentin Coatsaliou, Fabien Largyre, Caroline Caradu, et al. Journal of Endovascular Therapy. 2024 May 9.https://doi.org/10.1177/15266028241252097

This paper explores whether machine learning techniques can improve the prediction of arteriovenous access survival and avoid failures in patients transitioning from central venous catheters to arteriovenous fistulas or grafts. It was published as an Editor's choice paper in EJVES November 2024.Shownotes:Editor's Choice – Challenges of Predicting Arteriovenous Access Survival Prior to Conversion from CatheterHofmann, Amun G et al. European Journal of Vascular and Endovascular Surgery, Volume 68, Issue 5, 654 - 662, November 2024

Editor-in-chief of the European Journal of Vascular and Endovascular Surgery (EJVES), Prof. Martin Björck, and Senior Editor, Assistant Prof. Jon Boyle joins Egle Kavaliunaite in today's podcast.Together, they discuss the latest EJVES Editorial on Reporting Standards, "Why Should You Submit Your Best Papers to the European Journal of Vascular and Endovascular Surgery?", published in the January 2025 issue. Read the editorial here: https://www.ejves.com/article/S1078-5884(24)00905-5/fulltext

Today we are going to discuss another Editor's Choice article from the European Journal for Vascular and Endovascular Surgery (EJVES). The title is: Association of Pedal Acceleration Time With Healing and Amputation Free Survival in Patients With Ulceration and Gangrene by Odette Hart et al from The University of Auckland and Waikato Hospital in Hamilton, New Zealand. The article was published as an Editor's choice in the European Journal of Vascular and Endovascular surgery in October 2024. Shownotes:Editor's Choice – Association of Pedal Acceleration Time With Healing and Amputation Free Survival in Patients With Ulceration and GangreneHart, Odette et al.European Journal of Vascular and Endovascular Surgery, Volume 68, Issue 4, 490 - 497https://www.ejves.com/article/S1078-5884(24)00471-4/fulltext

In this special series, core faculty members of the SVS Leadership Development Program, Dr. Manuel Garcia-Toca, Dr. Kenneth Slaw, and Steve Robischon, discuss the program origins, research regarding good leadership, and how to join.    Manuel Garcia-Toca, MD completed his MD at the Universidad Anahuac in Mexico (1999) and MS in Health Policy at Stanford University (2020). Dr. Garcia-Toca completed his residency in General Surgery at Brown University (2008) and a fellowship in Vascular Surgery at Northwestern University (2010). He will serve within the Department of Surgery in the Division of Vascular Surgery and Endovascular Therapy and the Division of Emory Surgery at Grady based primarily at Grady Memorial Hospital. Kenneth Slaw, PhD is the executive director of the Society for Vascular Surgeons.  Dr. Slaw received his master's and doctoral degrees in educational psychology from the University of Illinois. He has over 35 years of executive leadership experience in the medical society and philanthropic communities, having served in numerous previous roles, including as president of the American Association of Medical Society Executives, as chairman of the board of Make A Wish Illinois, and as senior staff member at the Academy of Pediatrics, where he assisted in efforts with the Pediatric Leadership Alliance Program, which has provided leadership skill building sessions for approximately 3, 000 physicians. Steve Robischon, PA-C is a Physician Assistant with the Division of Vascular and Endovascular Surgery at the Medical College of Wisconsin in Milwaukee, Wisconsin, and is also a member of the PA Section Steering Committee.   More about the SVS PA Section More about the SVS Leadership Program   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

Audible Bleeding editor Wen (@WenKawaji) is joined by 4th-year general surgery resident Sasank Kalipatnapu (@ksasank) from UMass Chan Medical School, JVS editor Dr. Forbes (@TL_Forbes), JVS-VS associate editor Dr. John Curci (@CurciAAA) to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Mota, Dr. Liang and Dr. Weinkauf, authors of the following papers.   Articles: The impact of travel distance in patient outcomes following revascularization for chronic limb-threatening ischemia Serum detection of blood brain barrier injury in subjects with a history of stroke and transient ischemic attack  Show Guests: Dr. Lucas Mota- third-year general surgery resident at the Beth Israel Deaconess Medical Center Dr. Patrick Liang- assistant professor at Harvard medical school and a practicing vascular surgeon at the Beth Israel Deaconess medical center.  Dr. Weinkauf - assistant professor with the Department of Surgery Division of Vascular and Endovascular Surgery at the University of Arizona College of Medicine  Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

In this episode of Audible Bleeding, editor Dr. Imani McElroy (@IEMcElroy) is joined by General Surgery PGY-4 Sasank Kalipatnapu(@ksasank) along with Dr.David Rigberg, MD (@drigberg), and Dr. Guillermo Escobar, MD (@GAEscobarMD) to discuss the Society for Clinical Vascular Surgery (SCVS) Rising Seniors / Incoming Fellows Program. This episode brings out a conversation exploring the history behind the development of the program, the current state of the program, and the overwhelming importance of the program in the current day. The episode also provides a broad overview of the content presented in the program and the reasoning behind the talks.    Guests: Dr. David Rigberg - Professor of Surgery, Division of Vascular and Endovascular Surgery, Gonda Vascular Center, Program Director for the Vascular fellowship and integrated vascular surgery residency at the David Geffen School of Medicine, UCLA, Los Angeles, California Dr. Guillermo Escobar- Associate Professor, Division of Vascular Surgery and Endovascular Therapy, Program Director for the Vascular Surgery Fellowship and Residency at Emory University School of Medicine   Relevant links: Rising Seniors / Incoming Fellows Program - Program Details SCVS - Fellows & Chief Residents Program SCVS - Young Vascular Surgeons Program   To apply for the Rising Seniors / Incoming Fellows Program, go to apply now! Audible Bleeding team: Dr. Imani McElroy is 1st year vascular surgery fellow at USC/LA and editor at Audible Bleeding Dr. Sasank Kalipatnapu, PGY-4 general surgery resident, Dept of Surgery, UMass Chan Medical School, Worcester, MA Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

Audible Bleeding contributor and first year vascular surgery fellow Richa Kalsi (@KalsiMD) is joined by vascular fellow Donna Bahroloomi (@DonnaBahroloomi),  fourth year general surgery resident, Sasank Kalipatnapu (@ksasank), JVS editor-in-chief, Dr. Thomas Forbes (@TL_Forbes), and JVS-CIT editor Dr. Matt Smeds (@mattsmeds) to discuss two great articles in the JVS family of journals. The first article analyzes seven years worth of VQI data on TCAR, CEA, and TF-CAS to elucidate modern management of carotid disease. The second article provides a simple but powerful method of assessing adequacy of revascularization in the management of hemodialysis access-induced distal ischemia. This episode hosts Dr. Marc Schermerhorn (@MarcScherm), Sabrina Straus MS3 (LinkedIn), and Dr. Yana Etkin (@YanaEtkin), authors of these papers. Articles: Part 1: “Seven years of the transcarotid artery revascularization surveillance project, comparison to transfemoral stenting and endarterectomy” by Sabrina Straus, Dr. Schermerhorn, and colleagues. Part 2: “Proximalization of arterial inflow with adjunctive arterial pressure measurements for management of hemodialysis access-induced distal ischemia” by Dr. Etkin and colleagues. Show Guests: Sabrina Straus BS, 3rd year medical student at UCSD Dr. Marc Schermerhorn, George H.A. Clowes, Jr. Professor of Surgery, Harvard Medical School and Chief of Vascular and Endovascular Surgery, BIDMC Dr. Yana Etkin- Associate Professor of Surgery at the Zucker School of Medicine at Hofstra/ Northwell, Program Director for the Vascular Surgery Fellowship and Integrated Vascular Surgery Residency and Associate Chief of Vascular Surgery Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey. Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

In this episode of AbbottTalks, Jennifer Jones-McMeans, PhD, Divisional VP of Global Clinical Affairs at Abbott and Brian DeRubertis, MD, Chief, Division of Vascular & Endovascular Surgery at Weill Cornell Medical Center tackle the complexities of treating peripheral arterial disease (PAD) below the knee, particularly chronic limb-threatening ischemia (CLTI), a severe form of PAD that drastically impacts patients' quality of life and longevity. In the episode, the two discuss Abbott's Esprit BTK System, the first-and-only FDA-approved drug-eluting resorbable scaffold for infrapopliteal CLTI. Dr. Jones-McMeans explains how Esprit BTK works by releasing a drug that prevents artery re-narrowing, crucial for maintaining sustained blood flow and promoting wound healing. Later, they walk us through the pivotal LIFE-BTK trial, a significant milestone that demonstrated Esprit's efficacy and led to its FDA approval. They also highlight the importance of including diverse patient populations in clinical trials, particularly those disproportionately affected by PAD, such as African Americans, Latinos, Native Americans, and women. This inclusive approach not only ensures the treatment's effectiveness across varied demographics but also sets a precedent for future trials. Thank you to Freudenberg Medical for sponsoring this episode of AbbottTalks. For more information on how Freudenberg Medical works with medical device companies, visit www.freudenbergmedical.com. Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

In this episode, we discuss the challenges of explanting aortic grafts, the diagnosis and management of infected aortic grafts, as well as tips and tricks for once we're in the operating room.   Interviewers/Editors: Mark Basilious, MD Candidate (@markrbasilious) Eva Urrechaga, MD (@urrechisme) Sharif Ellozy, MD (@SharifEllozy)   Guests: Dr. Francis Caputo (@FrankCaputoMD) is an Associate Professor of Surgery at the Cleveland Clinic Lerner College of Medicine, Vascular Surgery Director of the Aorta Center, and Program Director of the Vascular Surgery Training Programs. His clinical interests include complex open and endovascular repair of thoracic, thoracoabdominal, and abdominal aortic aneurysms, management of thoracic dissection, and endovascular and open repair of failed endograft. Dr. Caputo earned his medical degree from the University of Medicine and Dentistry New Jersey, Newark, NJ, where he also served his surgical residency and two years as a National Institutes of Health research fellow. He completed his fellowship in vascular surgery at Barnes-Jewish Hospital of Washington University, St. Louis, MO and joined the Cleveland Clinic medical staff in 2018.    Dr. Peter Rossi (@peterjrossi) is a Professor of Surgery, Radiology, and Orthopedic Surgery, and Chief of the Division of Vascular and Endovascular Surgery at the Medical College of Wisconsin. His primary research and clinical interests are in complex  “re-do” and revision surgery, including for thoracoabdominal and abdominal aortic aneurysms, carotid artery surgery, and renal and mesenteric arterial disease, as well as vascular reconstruction for complicated soft tissue sarcomas. Dr. Rossi completed medical school at the University of Illinois College of Medicine before completing his general surgery training at the University of Chicago and his vascular surgery training at the Medical College of Wisconsin, where he has been a member of the faculty since 2009.  Dr. Xavier Berard (@XavierBerardMD)  is a French vascular surgeon who has been a Consultant in the Department of Vascular Surgery and Professor of Vascular and Endovascular Surgery in Bordeaux University Hospital in Bordeaux, France since 2010 and a full Professor of Vascular Surgery at the University of Bordeaux since 2016. He has also completed a PhD in Vascular Biomaterials and in 2010 worked as a research fellow at Lausanne University Hospital in Switzerland. He has been board certified by the French College of Vascular and Endovascular Surgeons since 2008 and by the European Society for Vascular and Endovascular Surgery since 2010. He has served as an examiner for the FEBVS exam since 2014 and as a reviewer for the European Journal of Vascular and Endovascular Surgery since 2016. Additionally, he is a member of the ESVS guidelines writing group for vascular graft infection and AAA.  His personal surgical interests include open surgery of (thoraco)abdominal aneurysms, redo aortic surgery, infections in vascular surgery, EVAR explantation, and biomaterials. He works closely with Institut Bergonié Bordeaux Cancer Center for sarcomas. You can see educational videos and learn more about Dr. Xavier Berard here. Helpful links and resources: Video of explantation of infected chimney EVAR with duodenal fistula (courtesy of Dr. Berard) Video of reimplanting the IMA after explanting an infected graft Video of explantation of infected graft with suprarenal fixation Videos of using the syringe technique to remove an aortic stent graft here and here (courtesy of Dr. Berard) References Kim YW. Aortic Endograft Infection: Diagnosis and Management. Vasc Specialist Int. 2023 Sep 21;39:26. doi: 10.5758/vsi.230071. PMID: 37732343; PMCID: PMC10512004. Papas TT. Patient Selection Is Essential for Explantation of Infected Abdominal Aortic Endografts. Angiology. 2023 Nov 23:33197231218622. doi: 10.1177/00033197231218622. Epub ahead of print. PMID: 37995099. Anagnostopoulos A, Mayer F, Ledergerber B, Bergadà-Pijuan J, Husmann L, Mestres CA, Rancic Z, Hasse B; VASGRA Cohort Study. Editor's Choice - Validation of the Management of Aortic Graft Infection Collaboration (MAGIC) Criteria for the Diagnosis of Vascular Graft/Endograft Infection: Results from the Prospective Vascular Graft Cohort Study. Eur J Vasc Endovasc Surg. 2021 Aug;62(2):251-257. doi: 10.1016/j.ejvs.2021.05.010. Epub 2021 Jun 14. PMID: 34140225. Lumsden AB. Explant of the Aortic Endograft: Today's Solutions, Tomorrow's Problems. Methodist Debakey Cardiovasc J. 2023 Mar 7;19(2):38-48. doi: 10.14797/mdcvj.1176. PMID: 36936357; PMCID: PMC10022536. Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

A 60-ish year-old client with a history of surgery for aortic aneurysm insists—INSISTS—that his 21-year-old massage therapist work with him, in spite of his new onset severe leg pain. What are the practitioner's options in this literally life-or-death scenario? This story, that looks cut-and-dried on the surface, is more complex than it appears. Plus, we get to talk about bulges in the aorta, bleeding ruptures, migrating devices, new surgical innovations, and much much more. Listen in to find out how it all turns out. Resources: Pocket Pathology: https://www.abmp.com/abmp-pocket-pathology-app Ameli, F.M. et al. (1987) ‘Etiology and management of aorto-femoral bypass graft failure', The Journal of Cardiovascular Surgery, 28(6), pp. 695–700. Choi, E. et al. (2021) ‘Risk Factors for Early and Late Iliac Limb Occlusions of Stent Grafts Extending to the External Iliac Artery after Endovascular Abdominal Aneurysm Repair', Annals of Vascular Surgery, 70, pp. 401–410. Available at: https://doi.org/10.1016/j.avsg.2020.06.028. Daye, D. and Walker, T.G. (2018) ‘Complications of endovascular aneurysm repair of the thoracic and abdominal aorta: evaluation and management', Cardiovascular Diagnosis and Therapy, 8(Suppl 1), pp. S138–S156. Available at: https://doi.org/10.21037/cdt.2017.09.17. Endovascular repair of complex aortic aneurysms - Mayo Clinic (no date). Available at: https://www.mayoclinic.org/medical-professionals/cardiovascular-diseases/news/endovascular-repair-of-complex-aortic-aneurysms/mac-20429867 (Accessed: 31 July 2024). Ivancev, K. and Vogelzang, R. (2020) ‘A 35 Year History of Stent Grafting, and How EVAR Conquered the World', European Journal of Vascular and Endovascular Surgery, 59(5), pp. 685–694. Available at: https://doi.org/10.1016/j.ejvs.2020.03.017. Modern History of Aortic Surgery, by Hazim J. Safi, MD | McGovern Medical School (no date). Available at: https://med.uth.edu/cvs/2020/08/25/modern-history-of-aortic-surgery-by-hazim-j-safi-md/ (Accessed: 31 July 2024). Park, K.-M. et al. (2017) ‘Long Term Outcomes of Femorofemoral Crossover Bypass Grafts', Vascular Specialist International, 33(2), pp. 55–58. Available at: https://doi.org/10.5758/vsi.2017.33.2.55. Sponsors: Anatomy Trains: www.anatomytrains.com  MassageBook: www.massagebook.com Elements Massage: www.elementsmassage.com/abmp

A 70 year old healthy female is referred to you with a 5.7 cm abdominal aortic aneurysm. As an astute clinician you are aware that current guidelines support surgical repair for her AAA. What if there was new data to suggest this patient may not benefit from repair? What would be the optimal size threshold that she would benefit from AAA repair? Tune into this episode of Behind the Knife, where the vascular surgery subspecialty team discusses a paper that challenges current size threshold guidelines for AAA repair.  Hosts:  Dr. Bobby Beaulieu is an Assistant Professor of Vascular Surgery at the University of Michigan and the Program Director of the Integrated Vascular Surgery Residency Program as well as the Vascular Surgery Fellowship Program at the University of Michigan. Dr. Frank Davis is an Assistant Professor of Vascular Surgery at the University of Michigan Dr. Drew Braet is a PGY-5 Integrated Vascular Surgery Resident at the University of Michigan Learning Objectives - Review the current size threshold guidelines for surgical repair of abdominal aortic aneurysms - Understand the limitations of the aforementioned guidelines - Understand the methodology, findings, limitations, and clinical applications of the manuscript “Size thresholds for repair of abdominal aortic aneurysms warrant reconsideration.” References 1.    Columbo JA, Scali ST, Jacobs BN, et al. Size thresholds for repair of abdominal aortic aneurysms warrant reconsideration. Journal of Vascular Surgery. 2024;79(5):1069-1078.e8. doi:10.1016/j.jvs.2024.01.017 https://pubmed.ncbi.nlm.nih.gov/38262565/ 2.    Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. Journal of Vascular Surgery. 2018;67(1):2-77.e2. doi:10.1016/j.jvs.2017.10.044 https://pubmed.ncbi.nlm.nih.gov/29268916/ 3.    Wanhainen A, Van Herzeele I, Bastos Goncalves F, et al. Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. European Journal of Vascular and Endovascular Surgery. 2024;67(2):192-331. doi:10.1016/j.ejvs.2023.11.002 https://pubmed.ncbi.nlm.nih.gov/38307694/ 4.    The UK Small Aneurysm Trial Participants, Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms.  Lancet 1998;352 (9141) 1649- 1655 https://pubmed.ncbi.nlm.nih.gov/9853436/ 5.    Lederle  FAWilson  SEJohnson  GR  et al. Aneurysm Detection and Management Veterans Affairs Cooperative Study Group, Immediate repair compared with surveillance of small abdominal aortic aneurysms.  N Engl J Med 2002;346 (19) 1437- 1444 https://pubmed.ncbi.nlm.nih.gov/12000813/ 6.    United Kingdom EVAR Trial Investigators; Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med. 2010 May 20;362(20):1872-80. doi: 10.1056/NEJMoa0911056. Epub 2010 Apr 11. PMID: 20382982. https://pubmed.ncbi.nlm.nih.gov/20382982/ 7.    Lederle FA, Johnson GR, Wilson SE, Ballard DJ, Jordan WD Jr, Blebea J, Littooy FN, Freischlag JA, Bandyk D, Rapp JH, Salam AA; Veterans Affairs Cooperative Study #417 Investigators. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA. 2002 Jun 12;287(22):2968-72. doi: 10.1001/jama.287.22.2968. PMID: 12052126. 8.    Lancaster EM, Gologorsky R, Hull MM, Okuhn S, Solomon MD, Avins AL, Adams JL, Chang RW. The natural history of large abdominal aortic aneurysms in patients without timely repair. J Vasc Surg. 2022 Jan;75(1):109-117. doi: 10.1016/j.jvs.2021.07.125. Epub 2021 Jul 26. PMID: 34324972. https://pubmed.ncbi.nlm.nih.gov/34324972/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Audible Bleeding contributor and 5th year general surgery resident Richa Kalsi (@KalsiMD) is joined by first-year vascular surgery fellow Zach Mattay (@ZMatthay), fifth-year general surgery resident Naveed Rahman (@naveedrahmanmd), JVS editor Dr. Thomas Forbes (@TL_Forbes), and JVS-CIT editor Dr. Matthew Smeds (@mattsmeds) to discuss two great articles in the JVS family of journals. The first article discusses national trends in surgeon-modified graft utilization for complex and thoracoabdominal aortic aneurysms. The second article discusses a novel technique, transcatheter electrosurgical aortic septotomy, to treat chronic dissecting aortoiliac aneurysms.  This episode hosts Dr. Thomas O'Donnell (@tfxod) and Dr. Carlos Timaran (@ch_timaran), the authors of these two papers. Articles: Part 1:“National Trends in utilization of surgeon-modified grafts for complex and thoracoabdominal aortic aneurysms” by Dr. O'Donnell and colleagues. Mentioned during the discussion:  “Application of Investigational Device Exemptions regulations to endograft modification” by Abel and Farb.  Part 2: “Early results of transcatheter electrosurgical aortic septotomy for endovascular repair of chronic dissecting aortoiliac aneurysms” by Dr. Timaran and colleagues. Mentioned during discussion: “Transcatheter Electrosurgery: JACC State-of-the-Art Review” by Khan and colleagues. “A Novel Way to Fenestrate a Type B Dissection Flap Using Endovascular Electrocautery” by Dr. Kabbani and colleagues.  Show Guests  Dr. Thomas O'Donnell: Assistant professor of surgery in the aortic center at New York Presbyterian/Columbia University Irving Medical Center. Dr. Carlos Timaran: Professor and Chief of Endovascular Surgery at University of Texas Southwestern Medical Center's Department of Surgery.   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

The ESVS is launching it's first aortic fellowship! In this 2-year program starting in September 2024 surgical trainees or vascular surgeons will have access to face-to-face and online workshops covering the full range of aortic surgery, topped by a two-week placement in a high-volume aortic centre. There is a beginner and an advanced module. ESVS members can apply for a Fellowship grant to cover the costs. Applications are open until July 1st. In this podcast, Dr. Igor Koncar explains the fellowship in more detail. Please find more information about the fellowship on the ESVS website (https://esvs.org/esvs-academy/aortic-fellowship/). Dr Igor Koncar, clinic for Vascular and Endovascular Surgery in Belgrade, Serbia and ESVS Academy Committee Chair.

Audible Bleeding editor Wen (@WenKawaji) is joined by 5th year general surgery resident Richa Kalsi (@KalsiMD) from University of Maryland Medical Center, 4th year general surgery resident Nitin Jethmalani from New York Presbyterian Hospital-Weill Cornell, JVS (@JVascSurg) editor Dr. Forbes (@TL_Forbes) and JVS-VL (@jvsvl) editor Dr. Bush (@ruthlbush) to discuss two great articles in the JVS family of journals regarding chronic pain and resident burnout and SFJ reflux and its implication in C2 and C3 chronic venous insufficiency. This episode hosts Dr. Pillado (@drpillado), Dr. Coleman (@ColemanDM_vasc) and Dr. Lal.    Articles:   Reported pain at work is a risk factor for vascular surgery trainee burnout by Dr. Pillado and colleagues. Effect of junctional reflux on the Venous Clinical Severity Score in Patients with Insufficiency of the great saphenous vein (JURY study) by Dr. Lal and colleagues.     Show Guests: Dr. Coleman: Professor of Surgery at Duke University and Division Chief of Vascular and Endovascular Surgery at Duke University Medical Center. Dr. Pillado: vascular surgery resident at Northwestern Hospital in Chicago, IL  Dr. Lal: Professor of Surgery at the University of Maryland, Professor of neurology at Mayo clinic, and professor of biomedical engineering at George Mason University. and Director of Center for Vascular Research at University of Maryland Medical Center   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

Join us for an insightful episode featuring Dr. Sukgu Han, Chief of the Division of Vascular Surgery and Endovascular Surgery at the Keck School of Medicine of USC. Dr. Han discusses his new role and exciting opportunities at Keck Medicine of USC, as well as changes he has implemented for great results. Explore the future growth prospects for both the medical school and the USC Comprehensive Aortic Center in this captivating conversation.

Audible Bleeding editor Matt Chia (@chia_md) is joined by Nishi Vootukuru (@Nishi_Vootukuru)  and Lili Sadri (@lilisadri) are joined by Drs. Joel Ramirez, James Iannuzzi, and James Pavel Kibrik to discuss their latest publications in the JVS family of journals.  Along with insight from JVS Assistant Editor Dr. Paul Dimuzio and JVS-VL Editor-in-Chief Dr. Ruth Bush (@RuthLBush), hear about the latest trends in AAA repair and the value of postoperative duplex after venous thermal ablation.  Don't miss it! Articles: Decreasing prevalence of centers meeting the Society for Vascular Surgery abdominal aortic aneurysm guidelines in the United States, by Ramirez et al. Value and limitations of postoperative duplex scans after endovenous thermal ablation, by Kibrik et al. Additional Links: Factors associated with ablation-related thrombus extension following microfoam versus radiofrequency saphenous vein closure, by Chin et al. Outcomes of a single-center experience in eliminating routine postoperative duplex ultrasound screening after endovenous ablation, by Woodhouse et al. Show guests: Joel Ramirez, MD - Integrated Vascular Surgery Resident at the University of California, San Francisco James C. Iannuzzi, MD MPH - Assistant Professor, Division of Vascular and Endovascular Surgery at the University of California, San Francisco Pavel Kibrik, DO - Graduate of New York Institute of Technology Osteopathic School of Medicine and current vascular surgery researcher at the NYU Langone School of Medicine  Ruth Bush, MD JD MPH FACS - Professor of Vascular Surgery and Associate Dean of Educational Affairs at the University of Texas, Medical Branch and Editor-in-Chief of the Journal of Vascular Surgery Venous and Lymphatic Disorders

Invitada: Dra. Gabriela Velázquez Egresada de la Universidad de Guadalajara Vascular and Endovascular Surgery, University of Florida College of Medicine Director for Vascular Surgery Fellowship Program, Vascular and Endovascular Surgery Wake Forest School of Medicine.  Anfitriones: Dr. Rodrigo Garza Herrera Dr. Fernando Guardado Bermúdez Conoce sobre la experiencia en uno de los Centros con mayor prevalencia de Isquemia Mesentérica, así como una casuística impresionante en revascularización de arteria mesentérica. Lectura recomendada: Surgical and endovascular revascularization of chronic mesenteric ischemia. Wolk et al. Langenbeck's Archives of Surgery (2022) 407:2085–2094  

Audible Bleeding editor Wen (@WenKawaji) is joined by second year medical student Nishi (@Nishi_Vootukuru), third year medical student Leana Dodge (@ldogbe4), JVS editor Dr. Forbes (@TL_Forbes) and JVS-VS associate editor Dr. Curci (@CurciAAA) to discuss two great articles in the JVS family of journals regarding Medicare reimbursement for complex endovascular aortic aneurysm repair and novel drug delivery method involving tissue factor targeting peptides in reducing vascular injury response. This episode hosts Dr.Brinster, Dr. Conte, and Dr. Kim, the authors of the following papers:   Articles:   Current Medicare reimbursement for complex endovascular aortic repair is inadequate based on results from a multi-institutional cost analysis by Brinster et al. Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries by Dr. Levy et al.     Show Guests: Dr. Clayton Brinster:  Associate Professor of Surgery at University of Chicago, and Co-Director of Center for Aortic Diseases, Department of Vascular Surgery and Endovascular Therapy Dr. Michael Conte: E.J. Wylie Chair, professor and chief of the division of Vascular and Endovascular Surgery at UCSF. Co-Directot of Heart and Vascular Center, Co-Director of UCSF Center for Limb Preservation and Diabetic Foot. Dr. Alexander Kim: Vascular surgery fellow and research fellow at UCSF   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

Audible Bleeding editor Wen (@WenKawaji) is joined by 5th year general surgery resident Richa Kalsi (@KalsiMD) from University of Maryland Medical Center, 3rd year general surgery resident Sasank Kalipatnapu (@ksasank) from UMass Chan Medical School, JVS editor Dr. Forbes (@TL_Forbes), and JVS-CIT editor Dr. Smeds (@matsmeds) to discuss two great articles in the JVS family of journals regarding endosuture aneurysm repair mid-term follow-up and endovascular repair of thoracic aortic aneurysm with aberrant subclavian artery. This episode hosts Dr. Frank Arko (@farkomd), Dr. Sukgu Han (@SukguH), and Dr. Fernando Fleischman, authors of the following papers:   Articles: Five-year outcomes of endosuture aneurysm repair in patients with short neck abdominal aortic aneurysm from the ANCHOR registry by Arko et al Sandwich thoracic branch endoprosthesis technique for endovascular repair of thoracic aortic aneurysm with aberrant right subclavian artery by Fleischman and Han et al   Show Guests: Dr. Arko is the Chief of Vascular and Endovascular Surgery with Atrium Health, Siverling Endowed Chair of vascular surgery clinical professor at Wake Forest University, and  co-director of Center for Aortic Disease at Sanger Heart and Vascular Institute. Dr. Sukgu Han is an Associate Professor of Surgery and Program Director for the residency/fellowship in the Division of Vascular Surgery and Endovascular Therapy at Keck School of Medicine of USC. He is also the Co-Director of the Comprehensive Aortic Center at Keck Hospital of USC.  Dr Fernando Fleischman is a cardiothoracic surgeon with extensive aortic expertise at Keck Hospital of USC. He is an Associate Professor of Surgery and Associate Program Director of cardiac surgery at USC. He is also the Co-Director of the Comprehensive Aortic Center.     Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

John Chuback, M.D., Monika Gloviczki, and M.D., Emily Iker, M.D. On today's Episode #36, Dr. Chuback, Dr. Iker, and Dr. Gloviczki welcomed DR. THOMAS MALDONADO. In this episode of the Lymphcast podcast, we're honored to host the distinguished Dr. Thomas Maldonado, Schwartz-Buckley endowed professor of surgery at NYU Langone Medical Center and a trailblazer in the field. Dr. Maldonado, with his extensive experience and notable role as Editor-in-Chief for Vascular and Endovascular Surgery, provides profound insights into the world of lymphedema treatment through surgery. Join our engaging discussion as we delve deep into the crucial role that surgical interventions play in effectively managing and treating lymphedema. Discover the evolving frontiers of surgical solutions and how they're transforming the lives of individuals affected by this condition. This episode is a must-listen for anyone seeking a comprehensive understanding of the potential that surgery holds in the pursuit of lymphedema relief. More about Dr. Maldonado: https://nyulangone.org/doctors/1477547206/thomas-maldonado

In this engaging episode of "A Life of Flow," we explore the world of vascular surgery through a unique lens: the dynamic between Dr. Vanessa Rubio and her father Dr. Gustavo Rubio. In this fully Spanish episode, we uncover their remarkable journey in medicine, how they've transformed their home into a hub of medical innovation, and their shared dedication to vascular surgery. The episode provides insight into the challenges and rewards of this medical specialty while discussing the latest trends and innovations in the field. Join us for a conversation that underlines the significance of vascular medicine and the special familial connection that drives their passion for it. Follow Life of Flow on Instagram Follow Life of Flow on Twitter Follow Dr. Miguel Montero-Baker on Twitter About Dr. Vanessa Rubio:Dr. Vanessa Rubio, a Medical Surgeon, graduated from the Universidad Autónoma de Guadalajara in 2003. She completed her medical studies with an impressive academic record and pursued diverse international experiences, including an internship in Barcelona and social service in Jalisco. Dr. Rubio specialized in General Surgery at Hospital Valentín Gómez Farías and Angiology and Vascular Surgery at Hospital Civil Fray Antonio Alcalde, both associated with the University of Guadalajara. Her extensive academic contributions include presentations and publications, and she is a member of renowned medical associations. Her dedication to advancing vascular surgery and her commitment to patient care have established her as a respected figure in the medical community.About Dr. Gustavo Rubio:Dr. Gustavo Rubio is a highly accomplished Medical Surgeon with a rich medical career. He obtained his professional degree from the Universidad Nacional Autónoma de México in 1979 and has since held various key positions. Dr. Rubio completed his residencies in General and Cardiovascular Surgery, becoming certified in both fields. He holds specializations in Thoracic Surgery, specifically Cardiac Surgery, and Angiology and Vascular Surgery. Over the years, he has actively pursued academic growth, including international fellowships and specialized training in Endovascular Surgery and Flebology. He is a distinguished member of multiple medical associations and has received recognition for his contributions, such as the "Pioneers in Performance" award in 2013. Dr. Rubio's dedication to the field and commitment to medical excellence make him a respected figure in the world of cardiovascular and vascular surgery.

Discover the next steps after a vascular screening, from diagnosis to treatment options. Dr. Justin Nelms, Chief of Vascular and Endovascular Surgery at University of Maryland Baltimore Washington Medical Center, sheds light on the importance of lifestyle changes, medication, and surgical interventions, providing valuable insights for a healthier future.

Dr. Matt Chia and Dr. Ezra Schwartz (@ezraschwartz10) continue the exploration of how vascular surgeons and patients communicate. They discuss how we share stories with one another and what may get lost in translation.   We are excited to welcome Katie Wright (@Translucentone) and Dr. Sherene Shalhub (@ShereneShalhub) to discuss the patient experience of living with Vascular Ehlers-Danlos Syndrome or vEDS.   Katie Wright is the vEDS Natural History Study project coordinator in the Division of Vascular Surgery at Oregon Health & Science University, a podcaster, and a patient advocate. They served as the Director of the Marfan Foundation's vEDS Division, The VEDS Movement until this past March, and they sit on the VEDS Collaborative (@vEDSCollabo) and Aortic Dissection Collaborative (@ADCollab) advisory board. Katie was diagnosed with vEDS in 2017 at the age of 28. Shortly after diagnosis, they started raising awareness and fostering community through YouTube videos. Katie then began a podcast titled Staying Connected, a space to share the stories of other patients and patient families. In 2018, Katie started volunteering on the advisory board of the vEDS Collaborative, a patient-centered research collaborative group led by Dr. Sherene Shalhub.    Dr. Sherene Shalhub is the inaugural John M. Porter Chair in Vascular Surgery and Division Head of the Division of Vascular and Endovascular Surgery at Oregon Health & Science University. She is also the Vice Chair of Regional Strategy & Surgical Operations for the Department of Surgery. Dr. Shalhub's research interests focus on improving healthcare and outcomes for those with genetic vascular conditions. She is the lead investigator for the vEDS Collaborative Natural History Study and the PCORI-funded Aortic Dissection Collaborative. Dr. Shalhub obtained an MPH followed by her medical degree at the University of South Florida. Dr. Shalhub completed her general surgery training at the University of Washington. She then pursued fellowships in trauma research and vascular surgery at the University of Washington.   Resources:   The VEDS Movement  VEDS Collaborative & Natural History Study If you are interested in taking part in the study or would like more information, please contact the study team VEDSColl@ohsu.edu Donate to the vEDS Natural History Study here. Aortic Dissection Collaborative for Patient-Centered Research | BeCertain.org Staying connected Episode: What Medical Professionals Should Know about VEDS Splenic artery pathology presentation, operative interventions, and outcomes in 88 patients with vascular Ehlers-Danlos syndrome Open repair of abdominal aortic aneurysms in patients with vascular Ehlers-Danlos syndrome Audible Bleeding Exam Prep Aortopathies Episode with Dr. Shalhub Free Chime Sound Effects Download - Pixabay   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

Vascular Team Talk is back with our second episode! This podcast mini-series is brought to you by the Society of Vascular Surgery Physician Assistant Section and Audible Bleeding. How does your Vascular team communicate or organize the day? Teams can consist of many people who have different responsibilities and due to the busy nature of vascular surgery services, it may be difficult to ensure urgent matters get passed on. In this episode, we focus on the importance of communication and relationships between vascular surgery students, residents, APPs, fellows and attendings.    Jessica Fernandes, PA-C, a Vascular Surgery physician assistant at Boston Medical Center (BMC), interviews Dr. Katie Shean, a vascular surgeon at St. Elizabeth's Medical Center, regarding the importance of communication and the transition from a fellowship to an attending position. Both Jessica and Dr. Shean discuss how they worked together at BMC and compare how Dr. Shean runs her current vascular team at St. Elizabeth's Medical Center.    Show Guests: - Jess Fernandes, PA-C, is an inpatient physician assistant in the Division of Vascular and Endovascular Surgery at Boston Medical Center. She is also a member of the SVS PA committee and NESVS PA committee. She graduated with her bachelor degree and Master in Physician Assistant Studies from MCPHS University in 2016.    - Katie Shean, MD is a vascular surgeon in the Division of Vascular and Endovascular Surgery at St. Elizabeth's Medical Center in Brighton, Massachusetts. She completed medical school at University of Vermont Medical School in 2013, followed by her general surgery residency at St. Elizabeth's Medical Center and vascular surgery fellowship at Boston Medical Center which she completed in 2022.    Show Links: SVS Physician Assistant Section St. Elizabeth's Medical Center Vascular and Endovascular Division  

In this captivating episode of the "Life of Flow" podcast, we sit down with a true pioneer in the field of vascular care, Dr. Peter Schneider. Join us as Peter shares his incredible journey from being fired from a job to becoming a successful entrepreneur and a leading figure in the world of vascular care. Get ready for a story of resilience, innovation, and unwavering dedication to making a positive impact on healthcare.Follow Life of Flow on Instagram Follow Life of Flow on TwitterFollow Dr. Miguel Montero-Baker on TwitterAbout Dr. Schneideer:Peter A. Schneider, M.D. is Professor of Surgery in the Division of Vascular & Endovascular Surgery at University of California San Francisco. Dr. Schneider received his MD from the Johns Hopkins School of Medicine and completed his general surgery residency and vascular surgery fellowship at the University of California San Francisco.Dr. Schneider was the founding member and chief of the Division of Vascular Surgery at Kaiser Permanente in Hawaii from 1994-2018. At Kaiser, he helped to develop a Diabetic Limb Treatment Program and a surveillance program for patients with aneurysms and a registry for patients with carotid disease used for surveillance. He oversaw the development of the first endovascular operating room in the Kaiser system.Dr. Schneider has served on numerous committees for the Society for Vascular Surgery and is the past president of Western Vascular Society where he also served on a number of its committees. He has been invited to numerous visiting professorships and has served as faculty or course director for many specialty courses. He authored "Endovascular Skills," the 4th edition, to be published in 2019, and has co-authored three other books on various aspects of vascular surgery. Dr. Schneider founded two medical device companies, served as an adviser to many others, and has been awarded numerous patents.

Audible Bleeding editors Wen (@WenKawaji) and Matt (@chia_md) are joined by Lara Lopes (@laralopesMD), Nitin Jethmalani (@nijethmalani), JVS editor-in-chief Thomas Forbes (@TL_Forbes), and JVS-VS Associate Editor Gale Tang, to discuss two great articles in the JVS family of journals.  This month's articles discuss the outcomes of aortic repair after Medicaid expansion, and the process of developing a novel device for repair of aortic injury.  Don't miss this fantastic discussion with the authors and editors at the forefront of vascular surgery!   Articles: Impact of Medicaid expansion on outcomes after abdominal aortic aneurysm repair by Ramadan et al. A dumbbell rescue stent graft facilitates clamp-free repair of aortic injury in a porcine model by Kenawy et al.   Show Guests: Omar Ramadan, MD - Chief General Surgery Resident at University of Pennsylvania Grace Wang, MD MSCE FACS - Director of the Vascular Lab and Associate Professor of Surgery in the Division of Vascular and Endovascular Surgery at the Hospital of the University of Pennsylvania Bryan Tillman, MD PhD - Vascular Surgeon Wexner Medical Center, Associate Professor of Surgery and Director of vascular research at the Ohio State College of Medicine   Audible Bleeding Contributors: Lara Lopes, MD - Vascular Surgery Integrated Resident, Northwestern University Nitin Jethmalani, MD - General Surgery Resident, Vascular Surgery Research Fellow, NYP Cornell   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

Modern-day evidence-based medicine mandates a strong understanding of current local and international guidelines. Surgeons rely heavily on these reports, but what to do when they differ? We have partnered with the ESVS podcast in creating the Transatlantic Series, where we compare and contrast our respective society guidelines. In this inaugural episode, we explore the SVS carotid artery disease guidelines published in 2022 and the recently updated ESVS guidelines published in 2023. Representing the American perspective, we are excited to speak with Dr. Ali AbuRahma. Dr. AbuRahma is the former president of the Society of Vascular Surgery, the Chief of Vascular and Endovascular Surgery at the Charleston Area Medical Centre at West Virginia University, and the corresponding author of the latest SVS guidelines on extracranial cerebrovascular disease. Representing the European perspective, we are delighted to speak with Dr. Barbara Rantner. Dr. Rantner is the co-chair of the 2023 European Society of Vascular Surgery Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease and a leading physician at the Ludwig-Maximillian University Hospital in Munich, Germany. Further reading and links: The North American Symptomatic Carotid Endarterectomy Trial (NASCET) & Audible Bleeding Landmark Papers NASCET Episode  Randomized trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) The 2nd European Carotid Surgery Trial (ECST-2): rationale and protocol for a randomized clinical trial comparing immediate revascularisation versus optimized medical therapy alone in patients with symptomatic and asymptomatic carotid stenosis at low to intermediate risk of stroke European Stroke Organisation (ESO) guideline on endarterectomy and stenting for carotid artery stenosis A comparative effectiveness study of carotid intervention for long-term stroke prevention in patients with severe asymptomatic stenosis from a large integrated health system SVS Patient Safety Organization (PSO) TCAR Surveillance Project SVS Vascular Quality Initiative (VQI) & VQI TCAR Registry Important recommendations of the German-Austrian S3 guidelines on the management of extracranial carotid artery stenosis (Paper only available in German)  Hosts: Laurence Bertrand is a 5th-year vascular surgery resident at the Ludwig Maximilian University Hospitals of Munich, Germany.  She is a medical graduate from KULeuven, Belgium, and has a Master of Science in International Health from the London School of Hygiene and Tropical Medicine.    Ezra Schwartz (@EzraSchwartz10) is a medical graduate from McGill University pursuing a Master of Medical Science in Medical Education at Harvard Medical School. He is applying to integrated vascular residency programs this year.  Please share your feedback through our Listener Survey! Follow us on Twitter (@audiblebleeding) and learn more about us at https://www.audiblebleeding.com/about-1/.  

Modern-day evidence-based medicine mandates a strong understanding of current local and international guidelines. We surgeons often rely heavily on these reports, but what to do when they differ? To explore this topic, Audible Bleeding (a publication of the SVS) and the ESVS podcast have partnered to create the Transatlantic Series. In this inaugural episode, we compare and contrast the SVS carotid artery disease guidelines published in 2022 with the recently updated ESVS guidelines published in 2023.Representing the American perspective, we are excited to speak with Dr. Ali AbuRahma. Dr. AbuRahma is the former president of the Society of Vascular Surgery, the Chief of Vascular and Endovascular Surgery at the Charleston Area Medical Centre at West Virginia University, and the corresponding author of the latest SVS guidelines on extracranial cerebrovascular disease.Representing the European perspective, we are delighted to speak with Dr. Barbara Rantner. Dr. Rantner is the co-chair of the 2023 European Society of Vascular Surgery Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease and a leading physician at the Ludwig-Maximillian University Hospital in Munich, Germany.

Audible Bleeding editor Wen (@WenKawaji) and  Matt (@chia_md) are joined by MD/PhD student Rahul Ghosh (@ghoshrx), JVS editor-in-chief Dr. Thomas Forbes (@TL_Forbes), and JVS Assistant Editor Dr. Paul Dimuzio (@pdimuziomd), to discuss two great articles in the JVS family of journals regarding renal stenting in the CORAL trial and metformin in AAA progression. This episode hosts Dr. Baohui Xu and Dr. Gregory Modrall, the authors of the following papers:    Articles: Mechanisms and efficacy of metformin-mediated suppression of established experimental abdominal aortic aneurysms by Xu et al.  Retrieval of renal function after renal artery stenting improves event-free survival in a subgroup analysis of the Cardiovascular Outcomes in Renal Atherosclerotic Lesions trial by Modrall et al.  Show Guests: Dr. Gregory Modrall - Professor of Surgery, Division of Vascular and Endovascular Surgery at The University of Texas Southwestern Medical School Dr. Baohui Xu – Senior research scientist at Stanford University in collaboration with ShanDong First Medical University in Jinan. Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

Show Notes Sharif is a vascular surgeon currently living in Manhattan. After graduating from Harvard in 1992, he went to NYU for medical school. He completed his residency and fellowship at Mount Sinai and was on faculty there for 12-13 years before going to Cornell in 2016.  Sharif is also a father of two sons, and, throughout the years, he  has managed to maintain some of his Harvard friendships and connections to his family in Egypt. He is currently part of the Society for Vascular Surgeries Communication Council to help raise awareness of the field. The Role and Responsibilites of a Vascular Surgeon Vascular surgeons are responsible for diseases involving blood vessels outside the heart and brain. Sharif explains how they treat these diseases with open surgical techniques, including bypasses, stents, and balloons. Vascular surgeons  also work with orthopedic surgeons, cancer surgeons, neurologists, or any time there is a challenge when dealing with blood vessels. Sharif talks about the diseases he commonly treats and the techniques he uses to perform surgery such as magnification in addition to muscle memory through repetition, and vascular repair techniques. Sharif discusses his work as the Program Director for the Vascular Surgery Fellowship of New York Presbyterian Hospital, which he has been running since 2016. To further trainees' education, Sharif has been involved in simulation training and runs a boot camp that has been operating since 2017. The boot camp is an in-person course with faculty from across the country and focuses on the technical side of vascular surgery and is designed to teach techniques without putting patients at risk. The program uses endovascular simulator and cadaver workshops to provide trainees with hands-on experience. This also gives them a chance to get to know the wider vascular community.  The Vascular Podcast, Audible Bleedings Sharif's most proud accomplishment is the podcast he was asked to produce with the trainees. This podcast, Audible Bleedings, which was bought out to be the official podcast for the Society of Vascular Surgery, was trainee-driven and has become increasingly popular in the past couple of years. This is a great way for trainees to develop their content and professional development. On the podcast, Sharif interviews prominent vascular surgeons, giving listeners insight into the personal life of a vascular surgeon, how they approach the difficulties in their work, and what the process of being a vascular surgeon looks like. During the pandemic, his podcast provided the vascular community with knowledge and insight.  He interviewed two of his colleagues from Seattle, Ben Starnes and Nitin Singh, who are both vascular surgeons and military surgeons, to discuss the impact of the COVID-19 pandemic in Seattle. He also had another guest, Mel Sheehan, a vascular surgeon at LSU, who had been there during Katrina and stayed throughout the pandemic. The conversation focused on how to respond to unexpected situations and the process of being a vascular surgeon.  Recent Developments in Vascular Surgery Sharif points out that there are many specialists in the field, and talks about his focus, his practice, and recent developments in vascular surgery, including endovascular simulation and remote access points when the focus is on endovascular repair of abdominal aortic aneurysms. This procedure has revolutionized the treatment of these aneurysms, allowing patients to come in, have the procedure done percutaneously, under local anesthetic, and go home the next day. This technology has allowed for a much less invasive and much more convenient way of treating aneurysms, making it a major development in the field. He also talks about the limitations of current technology when it comes to repairing aneurysms. He explains that it can be difficult to maintain blood flow to branch vessels, such as the arteries to the kidneys and intestines, while also excluding the aneurysm. To solve this problem, devices have been developed that have branches with holes to maintain blood flow while still excluding the aneurysm. It is also possible to print out a 3D model of the vessel ahead of time to help in designing the device. CAT can be used to create a 3D model of a patient's blood vessels.  Industry Collaboration in Health Innovations Vascular surgeons continuously need to develop technology to help patients. To do this, they have to partner with industries that have the resources to develop new technology, and that it is important to seek out industry partners to provide necessary support and experience. In order to create solutions for patients, it is essential that vascular surgeons and industry collaborate. He mentions that it is the surgeon's goal to do what is best for the patient and that they must remain aware that the job of industry is to sell the device.  When reflecting on his career, Sharif initially found general surgery attractive because of the dynamic nature of the work and the ability to offer patients medical and surgical therapy. However, he grew to like vascular surgery due to its meticulous nature and the fact that it allows for minimally invasive procedures. He found his mentor, Dr. Michael Marion, Chief of the Vascular Division, and Dr. Larry Hollier to be inspiring and both were a major factor in his decision to pursue the specialty.  Professors and Courses of Influence Ellozy also recalled his college days at Harvard where he found courses such as Literature Arts where he read Chaucer, and Ethics, and International Relations. However, he found the most impactful course was  Cultural Illness and Healing taught by Arthur Kleinman. He specifically remembers a book they read called Forgive and Remember, which was written to help physicians deal with medical errors. Timestamps: 09:21 Treating Aneurysms, Clots, and Varicose Veins  11:42 Surgical Suturing Techniques  16:38 Audible Bleedings Podcast  19:39 Vascular Surgery and the Impact of the COVID-19 Pandemic  20:30 Vascular Surgeon's Practice: A Day in the Life  24:46 Endovascular Surgery and Simulation  30:55 Endovascular Repair of Abdominal Aortic Aneurysms  34:32 The use of New Technology in Healthcare  37:32 Becoming a Vascular Surgeon and Harvard College Experiences  Links: Forgive and Remember  AudibleBleeding.com CONTACT INFO: https://www.instagram.com/sharifellozy/?hl=en https://www.linkedin.com/in/sharif-ellozy-215a2920/  

Audible Bleeding editor Wen Kawaji (@WenKawaji) is joined by MD/PhD student Rahul Ghosh (@ghoshrx), JVS editor-in-chief Dr. Thomas Forbes (@TL_Forbes), JVS Assistant Editor Dr. Paul Dimuzio (@pdimuziomd), and Associate Editor of the Journal of Vascular Surgery-Cases, Innovations and Techniques, Dr. Sherene Shalhub (@ShereneShalhub, @OHSUvascular), to discuss two great articles in the JVS family of journals regarding uncommon vascular conditions, including aberrant subclavian artery/Kommerell's diverticulum and vascular Ehlers-Danlos syndrome. This episode hosts Dr. Jonathan Bath, Dr. Peter Lawrence, and Dr. Bernardo Mendes, the authors of the following papers:   Articles: Contemporary Outcomes after Treatment of Aberrant Subclavian Artery and Kommerell's Diverticulum by Bath et al. Open repair of an infected abdominal aortic aneurysm in a patient with vascular Ehlers-Danlos syndrome by Mendes et al. Show Guests: Dr. Jonathan Bath (@MizzouVascular) -  Assistant Professor of Surgery and program director for vascular fellowship at the University of Missouri Dr. Peter Lawrence - Professor of surgery at @UCLAVascular, served as senior editor for both JVS and JVS-VL previously.  Dr. Benardo Mendes (@drbermendes) - Consultant in the Division of Vascular and Endovascular Surgery at Mayo Clinic, and is Associate Professor of Surgery at Mayo Clinic College of Medicine and Science.  Additional Notes: Vascular Low Frequency Disease Consortium Website  Visit here for a list of completed projects and publications. The VEDS Collaborative research study is still enrolling! Any patient interested in enrolling should reach out to VEDSColl@ohsu.edu and follow @VEDSCollabo and @OHSUvascular on Twitter. JVS-CIT will be dedicating a full virtual issue to patients with genetic aortopathy and arteriopathy. Resources for patients: https://thevedsmovement.org/ and https://www.ehlers-danlos.com/  Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  

In today's episode, Gowri Gowda, Ezra Schwartz and Morgan Gold, and Dr. Sharif Ellozy interview Dr. Daniel Silverberg about his experiences practicing and teaching vascular surgery in Israel. Dr. Silverberg is the deputy director of the Department of Vascular Surgery and the Director of the endovascular service at the Chaim Sheba Medical Center in Ramat Gan in the municipality of Tel Aviv, Israel. He completed his undergraduate medical studies with honors at the Ben-Gurion University of the Negev in Beer-Sheva, Israel, and his clinical internship year at Meir Medical Center, Kfar-Saba, Israel. Dr. Silverberg performed his general surgery training at Meir Medical Center, Kfar-Saba, Israel, and later at Mount Sinai Medical Center, New York City. He then remained at Mount Sinai, where he completed his vascular surgery fellowship. Dr. Silverberg worked as an attending vascular surgeon at the James J. Peter VA Medical Center in New York for three years until returning to Israel in 2009.  Contact Information for Dr. Daniel Silverberg Email: daniel.silverberg@sheba.health.gov.il   Twitter: Dr. Gowri Gowda (@GowriGowda11) Dr. Ezra Schwartz (@ezraschwartz10) Dr. Morgan Gold (@MorganSGold)   Articles, resources, and societies referenced in the episode: Israeli Society for Vascular and Endovascular Surgery:  https://israelivascular.ima.org.il/ViewEvent.aspx?EventId=3630 https://www.commonwealthfund.org/international-health-policy-center/countries/israel Zhang LP, Silverberg D, Divino CM, Marin M. Building a Sustainable Global Surgical Program in an Academic Department of Surgery. Ann Glob Health. 2016 Jul-Aug;82(4):630-633. doi: 10.1016/j.aogh.2016.09.003. Epub 2016 Oct 1. PMID: 27986231.   Follow us @AudibleBleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

Audible Bleeding team Matt Chia (@chia_md) and Gowri Gowda (@GowriGowda11) are joined by the co-principle investigators of the BEST-CLI trial, Dr. Matthew Menard and Dr. Alik Farber.  We talk about the results of BEST-CLI, marking what is sure to be the next landmark trial in vascular surgery.  Drs. Menard and Farber give their insights on being clinical trialists and surgeons in the modern era, reflecting on challenges in conducting this work and its broad-reaching implications. Links: Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia Comprehensive List of BEST-CLI Literature Show Guests: Dr. Matthew Menard (@MattMenard6) is the program director for the vascular and endovascular fellowship program and co-director of the Endovascular Surgery Program at Brigham and Women's Hospital. He is a vascular and endovascular surgeon at BWH and an Associate Professor of Surgery at Harvard Medical School. Dr. Alik Farber is the Chief of the Division of Vascular and Endovascular Surgery at Boston Medical Center and Professor of Surgery and Radiology at Boston University School of Medicine Follow us @AudibleBleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

Vascular surgery is full of awesome anatomy and big open vessel exposures, but endovascular surgery is here to stay and can be hard to get into, particularly as a learner. The basics of endovascular surgery share very little with the basics of open surgery and getting up to speed can be a big challenge. This episode is an introduction to all things endovascular surgery, from wires, catheters and sheaths to balloons and stents. Take a listen to get up to speed quickly in prep for an upcoming vascular rotation and skip the pain of trying to follow your attendings words so you can instead pay attention to the actual case. Dr. Frank Davis is an Assistant Professor of Vascular Surgery at the University of Michigan. Dr. Craig Brown is a PGY-7 in the General Surgery program and the upcoming 2023 vascular surgery fellow at the University of Michigan. Check out the accompanying video for this episode available here: https://behindtheknife.org/video-playlists/podcast-clips/ Ad referenced in episode: A team at the Brooke Army Medical Center is working to better define proficiency-based metrics for competency in commonly performed robotic general surgery procedures. If you are a general surgery resident or practicing surgeon who performs robotic assisted cholecystectomies or inguinal hernia repairs,  reach out to the PI, Robert Laverty, MD, at rblaverty@gmail.com for more information on how you could be compensated $500 per video submitted of each (up to $1000 per surgeon). To check out our Vascular Surgery Oral Board Audio Review and Book, please visit: https://behindtheknife.org/premium/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

The first of a 2-part interview on mesenteric ischaemia with expert in the field professor Bob Geelkerken.In this episode we talk about the different forms of mesenteric ischemia (acute, chronic, venous) and clinical challenges in diagnosis and treatment. Great to refresh or deepen your knowledge on this topic.Please also check the show notes for literature references if you are interested. Keep an eye out for the second part of the interview which is focussed completely on median arcuate ligament syndrome (MALS) - and if it exists or not..!Shownotes:Björk et al; Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS), European Journal of Vascular and Endovascular Surgery, Volume 53, Issue 4, 2017, Pages 460-510,DOI: https://doi.org/10.1016/j.ejvs.2017.01.010Terlouw et al; European guidelines on chronic mesenteric ischaemia. United European Gastroenterol J. 2020 May;8(4):371-395DOI: 10.1177/2050640620916681Huber et al; Chronic mesenteric ischemia: Clinical practice guidelines from the Society for Vascular Surgery. J Vasc Surg 2021 Jan;73(1S):87S-115SDOI: 10.1016/j.jvs.2020.10.029Bjork and Huber; Chronic Mesenteric Ischaemia, the Transatlantic Perspective. Eur J Vasc Endovasc Surg 2021 Feb;61(2):177-178DOI: 10.1016/j.ejvs.2020.12.013Van Dijk et al; Validation of a score chart to predict the risk of chronic mesenteric ischemia and development of an updated score chart. United European Gastroenterol J 2019 Nov;7(9):1261-1270DOI 10.1177/2050640619856765Vaassen et al; Intraoperative quantification of fluorescence angiography for assessment of intestinal perfusion: in vivo exploration of clinical value. BJS Open 2022 May 2;6(3):zrac058DOI: 10.1093/bjsopen/zrac058Contact the mesenteric ischemia expert group in the Medisch Spectrum Twente trough: vaatchirurgie@mst.nl

     Dr. Rasmussen is a retired Air Force Medical Corps officer and is currently a Professor of Surgery and Vice Chair of Education in the Department of Surgery at the Mayo Clinic College of Medicine and Science in Rochester, Minnesota.     In this episode, you will hear about how Military Vascular Surgeons are trained and about their role in providing expert care on the battlefield.  Col Rasmussen had the opportunity to deploy multiple times across the globe and shares how Military Medicine prepares and provides care from the tip of the spear through the evacuation chain to medical centers in the United States.  Dr. Rasmussen explains how the work of he and his colleagues at the US Army Institute of Surgical Research and with the DoD Combat Casualty Care Research Program used data-driven research to improve how coalition forces care for wounded service members.  He also is an incredibly talented Vascular Surgeon, and he shares some insights and lessons he's learned from memorable cases over his distinguished career.    Dr. Rasmussen received his medical degree from the Mayo Clinic College of Medicine and trained in General Surgery at Wilford Hall Air Force Medical Center. He returned to the Mayo Clinic for fellowship training in vascular surgery. He has deployed multiple times to combat zones and has held numerous leadership positions in Military Medicine before retiring and returning to the Mayo Clinic as a Senior Associate Consultant in the Division of Vascular and Endovascular Surgery.          Find out more and join Team WarDocs at www.wardocspodcast.com Honoring the Legacy and Preserving the History of Military Medicine The WarDocs Mission is to improve military and civilian healthcare and foster patriotism by honoring the legacy, preserving the oral history, and showcasing career opportunities, experiences, and achievements of military medicine. Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible, and 100% of donations go to honoring and preserving the history, experiences, successes, and lessons learned in military medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield, demonstrating dedication to the medical care of fellow comrades in arms.           Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast

John Chuback, M.D., Monika Gloviczki, M.D., Emily Iker, M.D., and Mark Melin, M.D. On today's Episode #14, Dr. Chuback, Dr. Iker, Dr. Gloviczki, and Dr. Melin welcomed DR. PETER GLOVICZKI, M.D., From his BIO from the Journal of Vascular Surgery: "Peter Gloviczki, MD, FACS, is the Editor-in-Chief of the Journal of Vascular Surgery Publications, a position he has held since July of 2016. He is the Joe M. and Ruth Roberts Professor of Surgery (Emeritus) of the Division of Vascular and Endovascular Surgery at Mayo Clinic, Rochester, Minnesota. He served as Division Chair (2000 - 2010) and as Director of the Mayo Clinic Gonda Vascular Center (2002 - 2010). Dr. Gloviczki earned his medical degree in 1972 at Semmelweis Medical University in Budapest, Hungary, with distinction (Sub Auspiciis Rei Publicae Popularis). He completed his general and vascular surgery trainings in Budapest, at the St. Michel and St. Joseph hospitals in Paris, France and at Mayo Clinic in Rochester, Minnesota, where he joined the staff in 1987. Dr. Gloviczki had extensive clinical practice that included all areas of vascular surgery: arterial, venous and lymphatic. While on the staff at Mayo Clinic, he performed over 10,000 operations. He has a special interest in aortic, mesenteric, and renovascular surgery, critical limb ischemia. He is an expert in reconstruction of large veins, in endoscopic perforator vein surgery, vascular malformations, chronic venous insufficiency, in lymphatic and chylous disorders. He is author of 456 peer-reviewed publications, wrote over 250 book chapters, editorials and reviews and has given more than 600 presentations. He mentored 85 categorical vascular surgery fellows and 25 research fellows. He was Editor-in-Chief of Perspectives in Vascular Surgery and Endovascular Therapy and Vascular and Endovascular Surgery. He edited eight textbooks, including the Handbook of Venous and Lymphatic Disorders. He was Associate Editor of Rutherford's Vascular Surgery, 4th, 5th, 6th, 7th and 8th editions. Dr. Gloviczki was President of the Society for Vascular Surgery (SVS), the World Federation of Vascular Societies, American Venous Forum (AVF), Society for Clinical Vascular Surgery (SCVS), International Union of Angiology, Vascular Disease Foundation, the American Venous Forum Foundation, the Midwestern Vascular Surgical Society, the Gulf Coast Vascular Society, and served as Honorary President of the Société Francaise D'Angéologie."

Today, Gowri and our Holding Pressure team republish the Vascular and Endovascular Surgery Society (VESS) National Student-Run Vascular Surgery Interest Group (VSIG) Webinar on "Discover: Vascular Surgery."  This webinar originally occurred on November 10, 2022.  Featured Physician Speakers:  Gabriela Velazquez MD, FACS, RPVI; Associate Professor, Program Director Vascular and Endovascular Surgery Fellowship, Director Vascular Surgery Clerkship; Department of Vascular and Endovascular Surgery, Wake Forest University School of Medicine Todd Berland, MD, FACS, RPVI; Associate Professor of Surgery, Division of Vascular Surgery at NYU Grossman School of Medicine; Director, Outpatient Vascular Interventions NYU Langone Health Ravi Rajani, MD, FACS, DFSVS; Professor of Vascular Surgery, Assistant Dean for Medical Education, Emory University School of Medicine; Chief, Vascular and Endovascular Surgery, Co-Director, Grady Heart and Vascular Center, Grady Memorial Hospital VESS VSIG Team/Moderators Audible Bleeding Resources: Episodes geared towards medical students: Audible Bleeding (Holding Pressure)  Exam Prep Book: https://adam-mdmph.quarto.pub/vascular-surgery-exam-prep/ VESS VSIG Resources for Medical Students interested in Vascular Surgery:  VESS membership link: https://vesurgery.org/my-vess/why-join-vess Website: https://vesurgery.org/vess-vsig/ Email: vessvsig@gmail.com VESS VSIG Resources for Medical Students: publication date TBD; stay tuned for an updated link once published

“When I talk about family history, I tell people to look at the people in their family. See what it is that bothers them. Why is that important? You contain somewhere between 40 to 70% of the genetic material of each of your parents. And it'll be in a different mixture based on the way the good Lord wanted it to come out. But if both of your parents have high blood pressure, and both of your parents have high cholesterol, and both of your parents have had strokes at an early age, and you do the same things that they did, such as eat lots of cholesterol, fried foods, smoke cigarettes, you're probably going to have a stroke as well,” explains Dr. David Chatman. Dr. David Chatman is currently the Medical Director of Focused Claims Review in Vascular and Endovascular Surgery at Optum Health Care following a successful career as vascular surgeon. He talks with host D-Rich about the importance of communicating and understanding your family medical history. They are joined by Dr. Allison Matthews, Executive Director and Research Fellow in Faith and Health, to discuss the stigma surrounding HIV in the Black community.    Historically, the Black community and Black churches have not been very accepting of the LGBTQ community and as such there is a large stigma surrounding HIV. People prefer to act like HIV does not exist and to stay silent. This leads to HIV-positive Black and Brown individuals being uncomfortable with seeking care or even just speaking with their families about their experiences. Talking about HIV status is not the only medical issue that the Black community struggles with. Many adults prefer not to talk about any of their health concerns or medical history with others, even their own children. It is vital that we normalize having these discussions in an understanding and compassionate way because knowing your family medical history could be the difference between life and death in many cases.   It can be difficult to have conversations about medical concerns. Many people delay going to the doctor because they would rather not know something is wrong. By working to remove the stigma surrounding medical conditions, we can make it easier for people to choose to seek out care.    Quotes • “Nationally we don't really have a lot of faith based initiatives around HIV, because of the stigma. A lot of people don't agree with homosexuality in the Black community and in Black churches in particular. Unfortunately, churches have been one of the main sources of stigma around HIV. We were founded in 2021 to coordinate efforts to put money into faith based organizations that are committed to addressing HIV stigma in a responsible and compassionate way.” (5:21-6:02 | Dr. Allison) • “The common thread through faith communities and our families is silence. I think a big reason why HIV has so much stigma is because we like to sweep things under the rug and act like things never happen. But our silence is what's killing us.” (18:44-19:08 | Dr. Allison)  • “The thing that I like to share with the community and people who tend to be in what I call pockets of ignorance is information that's readily available to people who are in higher socioeconomic status, etc. And I like to say that these are situations that we need to talk to each other about. We need to educate each other about in order to fill these gaps.” (37:05-37:39 | Dr. David) • “When I talk about family history, I tell people, look at the people in your family. See what it is that bothers them. Why is that important? You contain somewhere between 40 to 70% of the genetic material of each of your parents. And it'll be in a different mixture based on the way the good Lord wanted it to come out. But if both of your parents have high blood pressure, and both of your parents have high cholesterol, and both of your parents have had strokes at an early age, and you do the same things that they did, such as eat lots of cholesterol, fried foods, smoke cigarettes, you're probably going to have a stroke as well.” (43:16-43:59 | Dr. David)   Links   Community Health Activation - Enabling Preventative and Restorative Health with Dr. Allison Mathews    Connect with Dr. Allison Mathews: Website: https://drallisonmathews.com/ Linkedin: https://www.linkedin.com/in/allisonmathews/   Dr. Allison Mathews serves as Executive Director and Research Fellow in Faith and Health. She specializes in integrating technology, social marketing, community engagement, and social science to examine the intersections of race, class, gender, sexuality, and religiosity on HIV-related stigma and to innovate clinical research engagement and access to health care for underserved populations. Dr. Mathews has been invited to speak about HIV and COVID-19 on national and international platforms, including TEDxCaryWomen. Dr. Mathews is the founder of Community Expert Solutions (CES). CES innovates community engagement for clinical trial research and public health campaigns using qualitative research, social marketing, technology, and crowdsourcing expertise. CES aims to build our clients' capacity to serve their communities more effectively while promoting health equity.   Normalizing Family Medical History and Understanding - Enabling Preventative and Restorative Health via Community Activation with Dr. David Chatman   Connect with Dr. David Chatman: Linkedin: https://www.linkedin.com/in/david-chatman-md-facs-b4263535/ Twitter: https://twitter.com/DMCQuePsiPhi   Dr. Chatman graduated from Vanderbilt University in 1985, then completed medical school at the James Quillen College of Medicine. His General Surgery and Vascular Surgery training were accomplished at Howard University and the Ochsner Clinic, respectively. He practiced General Vascular Surgery in Murfreesboro, TN, for 26 years. He has held many leadership positions in his healthcare community, on the Vanderbilt University Alumni Board, and in the Association of Vanderbilt Black Alumni. He is a member of Omega Psi Phi Fraternity, Inc., and recently retired from his practice of Vascular Surgery to accept a position at Optum Health Care as a Medical Director of Focused Claims Review in Vascular and Endovascular Surgery. He also recently began an MBA program at Case Western Reserve University's Weatherhead School of Management.   About with Southern Soul Live Stream - Podshow   Witty, thought-provoking, and uplifting, Southern Soul Livestream - Podshow is the program that you'll invite friends over to watch every week, where you'll learn about fascinating speakers and get to share in their exciting experiences. Tune in each Thursday at 8 pm eastern to connect with guests from across the generations and to laugh with our "cast of characters," hosts who are as charming as they are talented!   Enjoyed this episode? Support our hard work and exploratory journalism, Buy us  A Coffee!  Join The ShowExperience our live studio recordings “It's a Whole Vibe!” Click here to register.     Connect with us Website: www.SoulLiveStream.com Facebook: https://www.facebook.com/SouthernSoulLiveStream/ Instagram: https://www.instagram.com/southern_soul_livestream/ Twitter: https://twitter.com/soulthursdays

The COVID pandemic has resulted in increased rates of burnout and mental illness among surgeons. The quiet epidemic of mental illness continues to leave both surgical trainees and staff at increased risk of self-harm or suicide. In this episode, we talk with Dr. Carrie Cunningham and Dr. Dawn Coleman about their efforts to change the narrative and provide data on the impacts of mental health on surgical training and practices.  Disclaimer: Topics covered in this episode may be sensitive for some listeners. If you or someone you know is experiencing suicidal thoughts or a crisis, please get in touch with a trained professional or call 988 for the Suicide Prevention Lifeline. Guests Dr. Carrie Cunningham (nee Lubitz) (@lubitz_carrie) is an Associate Professor of Surgery at Harvard Medical School, Section head of the Massachusetts General Hospital Endocrine Surgery Unit, and Associate Director at the Massachusetts General Hospital Institute for Technology Assessment. Dr. Dawn Coleman (@DawnDM_vasc) is the newly appointed Division Chief for the Division of Vascular and Endovascular Surgery at Duke University. Additional Resources Vascular surgeon wellness and burnout: A report from the Society for Vascular Surgery Wellness Task Force If you need Mental Health Resources for Physicians or the National Suicide Prevention Lifeline. For more information on the Lorna Breen Foundation.  For more information about Jo Shapiro. What other topics would you like to hear about? Let us know more about you and your thoughts about our podcast through our Listener Survey or email us at AudibleBleeding@vascularsociety.org. Follow us on Twitter @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

In this episode, we explore the role of vascular surgeons in oncologic surgery. We will be discussing the nuances of vascular involvement in oncologic resection, common practices, and future directions of this collaborative surgical culture.   Dr. Adam Beck (@AWBeckMD) is a vascular surgeon and Professor of Surgery at the University of Alabama at Birmingham where he serves as the Director of the Division of Vascular Surgery and Endovascular Therapy, holds the Holt A. McDowell, Jr, MD Endowed Chair in Vascular Surgery and serves as the Director of Quality and Associate Chief Medical Quality Officer for the UAB Cardiovascular Institute. Dr. Beck completed his general surgery residency training and a surgical oncology research fellowship at the University of Texas-Southwestern Medical Center. He trained in vascular surgery at the Dartmouth-Hitchcock Medical Center and then completed a fellowship in advanced endovascular techniques, including branched and fenestrated endografts for aortic aneurysmal disease, at the University Medical Center of Groningen in The Netherlands. You can learn more about Dr. Adam Beck here.   Dr. Xavier Berard (@XavierBerardMD)  is a French vascular surgeon and serves as a Consultant in the Department of Vascular Surgery and Professor of Vascular and Endovascular Surgery in Bordeaux University Hospital in Bordeaux, France. He is board certified from the French College of Vascular and Endovascular Surgeons and from the European Society for Vascular and Endovascular Surgery. He has also completed a PhD in Vascular Biomaterials and has built a library of educational video content. He works closely with Institut Bergonié Bordeaux Cancer Center for sarcomas. You can see educational videos and learn more about Dr. Xavier Berard here   Dr. Sharif Ellozy (@SharifEllozy)  is a vascular surgeon at the New York-Presbyterian/Weill Cornell Medical Center where he serves as Associate Professor of Clinical Surgery in the Division of Vascular and Endovascular Surgery, and Program Director of the Vascular Surgery Fellowship program. He is also one of the founders of Audible Bleeding. He is readily involved in oncologic resection at the Memorial Sloan Kettering Cancer Center and works closely with surgical oncologists on operative cases that have vessel involvement.   Authors/Interviewers: Dr. Sree Kanna, MD - McGill, Montreal (@VulnerableAorta) Dr. Nakia Sarad, DO, MS - New York-Presbyterian/Queens - Weill Cornell, New York (@NakSaradDO)   Editors: Morgan Gold, MD,CM candidate - McGill, Montreal (@MorganSGold) Ezra Schwartz, MD,CM, MS, MMSc-Med Ed candidate - Harvard, Boston (@EzraSchwartz10)   Helpful Resources:   To learn more about sarcoma resections, check out the Schwarzbach papers on lower extremity sarcomas and retroperitoneal sarcomas   Click here to learn more about the NCCN Guidelines on Resectability of Pancreatic Cancers   Click here to learn more about IVC Reconstruction Techniques in Oncologic Surgery   Video of IVC Leiomyosarcoma Reconstructions here (courtesy of Dr. Berard)   Click here to learn more about the Renal Cell Carcinoma Mayo Staging System Click here to find the original article on the Shamblin Classification for Carotid Body Tumors   Check out this review paper on Oncovascular Surgery    Check out this paper on spiral endografts here Video of spiral saphenous vein graft technique here (courtesy of Dr. Berard)   What other topics would you like to hear about? Let us know more about you and what you think of our podcast through our Listener Survey or email us at AudibleBleeding@vascularsociety.org. Follow us on Twitter @audiblebleeding   Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.  

We are excited to have Dr. Robert Molnar, Dr. Anil Hingorani, and Dr. Edward Arous to discuss the SVS Sub-Section on Outpatient & Office Vascular Care (SOOVC). In 2018, the SVS created a new membership section for clinicians who work in outpatient and office vascular care centers. The section's mission is to establish a forum where members can work to advance the care of patients with vascular disease in outpatient settings by enhancing SVS efforts in education, advocacy, quality practice, ethics and research. Since its start, the section has grown to more than 130 members. It is now a subsection of the SVS Community Practice Section (SVSCPS).    Dr. Robert Molnar has practiced with the Michigan Vascular Center since 1998. He completed his undergraduate studies at the University of Notre Dame, his medical degree at the Medical College of Ohio, his General Surgery at Michigan State University and his Vascular Fellowship at Vanderbilt University. He serves as the chair of the SVS Community Practice Section and is on the SVS executive Board. One of his main interests is in high quality outpatient vascular care, especially in the OBL space.   Dr. Anil Hingorani has been practicing vascular surgery in Brooklyn, New York since 1998. He completed his undergraduate studies at Rensselaer Polytechnic Institute and graduated medical school from Albany Medical college. He performed his general surgery residency at St. Luke's Roosevelt Medical center at Columbia University and his vascular fellowship at Maimonides Medical Center. He serves as the chair of the Subsection  for Outpatient and Office Vascular Care. He is affiliated with NYU Langone in Brooklyn New York   Dr. Edward Arous received his medical degree from the University of Massachusetts Medical School, his master's in public health from the Harvard School of Public Health, and completed his residency in vascular surgery at the University of Massachusetts Medical School. Prior to joining The Vascular Care Group, Dr. Arous was an Assistant Professor of Vascular and Endovascular Surgery at the University of Massachusetts Medical School and the Director of the Limb Preservation Center.  Learn more about the SOOVC here: SVS SOOVC webpage  Learn more about the SVS Clinical Practice Section here: SVS Community Practice Section webpage   What other topics would you like to hear about? Let us know more about you and what you think of our podcast through our Listener Survey or email us at AudibleBleeding@vascularsociety.org. Follow us on Twitter @audiblebleeding   Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

We are very excited to have Dr. Bruce Gewertz on the pod today, with guest hosts Dr. Ali Azizzadeh and Dr. Ben Pearce. We discuss Dr. Gewertz's career as a surgeon-scientist, with an emphasis on the importance of emotional intelligence and the leadership lessons he has learned along the way.   Dr. Gewertz (@jackgiraffe1) is the H and S Nichols Distinguished Chair, Vice Dean for Academic Affairs and Vice President, Interventional Services at Cedars-Sinai Health System. Prior to his tenure at Cedars-Sinai, he spent 25 years at the University of Chicago, the last 14 of which as the Dallas Phemister Chair of the Department of Surgery. He also served as the inspiration for Harrison Ford's character, Dr. Richard Kimble, in the Academy Award nominated 1993 movie classic, “The Fugitive”, starring Harrison Ford and Tommy Lee Jones.     Dr. Ali Azizzadeh (@DrAliAzizzadeh)is a Professor and Director of the Division of Vascular Surgery at Cedars-Sinai, Vice Chair of the Department of Surgery, Associate Director, Smidt Heart Institute, and Associate Dean of Faculty Affairs. Before being recruited by Dr. Gewertz to join the staff at Cedars-Sinai in 2017, he served as Professor and Chief of Vascular and Endovascular Surgery at McGovern Medical School at UTHealth and the Memorial Hermann Heart and Vascular Institute in Houston, TX. Dr. Ben Pearce (@HawkeyeBJP) is the William D. Jordan, Jr. Endowed Professor of Vascular Surgery and Program Director of the Vascular Training Programs at the University of Alabama-Birmingham.   Dr. Pearce completed his general surgery residency at the University of Chicago Hospitals where he was mentored by today's guest. He even wore Dr. Richard Kimble's loupes as an intern! He then completed his fellowship at UAB in Vascular Surgery and was an assistant professor at UT Health before returning to Birmingham to take on his current position. He is pleased to count Dr. Gewertz as a trusted mentor, but, more importantly, dear friend for the past 22 years   Learn more about Dr. Gewertz here: https://brucegewertzmd.com/about/ Selected videos and publications by Dr. Gewertz   What other topics would you like to hear about? Let us know more about you and what you think of our podcast through our Listener Survey or email us at AudibleBleeding@vascularsociety.org. Follow us on Twitter @audiblebleeding   Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

Audible Bleeding editors Matt Chia and Wen Kawaji are joined by JVS Assistant Editor Dr. Paul Dimuzio and JVS Editor-in-Chief Dr. Thomas Forbes to discuss a recent article in the JVS.  They're joined by Dr. Elizabeth Andraska, the first author of the paper discussing long-term followup after EVAR, available now in the August 2022 issue of the JVS.  Find out how this paper can have an immediate impact on your patients, and hear insights directly from Dr. Andraska in this exciting episode!   Link to “Longer follow-up intervals following endovascular aortic aneurysm repair are safe and appropriate after marked aneurysm sac regression” by Andraska et al.: https://doi.org/10.1016/j.jvs.2022.01.079    Show Guests: Dr. Elizabeth Andraska (@eandraska) is in her sixth year of training in the integrated vascular surgery residency at the University of Pittsburgh. She has a Masters in Clinical Research from the University of Michigan and has completed two years of dedicated research time at the University of Pittsburgh. She is excited to pursue a career in academic vascular surgery.   Previous episode with Dr. Elizabeth Andraska on Getting Started with Basic Science in Vascular Surgery: https://www.audiblebleeding.com/getting-started-in-basic-science/    Previous episode with Dr. Thomas Forbes and Dr. Ron Dalman on the next chapter of the JVS: https://www.audiblebleeding.com/2022/06/14/interview-with-the-incoming-editors-of-the-jvs/    JVS Host Introductions: Dr. Paul Dimuzio (@pdimuziomd) is the William M. Measey Professor of Surgery, Director of the Division of Vascular and Endovascular Surgery at Thomas Jefferson University Hospital and Co-Director of the Jefferson Vascular Center in Philadelphia, as well as being one of the new Assistant Editors for the JVS. Dr. Thomas Forbes (@TL_Forbes) is the Surgeon-in-Chief and James Wallace McCutcheon Chair of the Sprott Department of Surgery at the University Health Network, Professor of Surgery at the University of Toronto, as well as being one of the new Editors-in-Chief for the JVS.   Audible Bleeding Host Introductions:  Dr. Wen Kawaji (@WenKawaji) is a general surgery resident at Medstar Health in Baltimore, MD. She is passionate about vascular, trauma, and critical care and recently completed a burn/surgical critical care fellowship at Johns Hopkins. Wen has been a loyal audible bleeding fan throughout residency and is excited to learn from and work with the podcast team. In her spare time, she enjoys traveling, food adventures, and puzzles. Dr. Matthew Chia (@chia_md) is in his final year of the integrated vascular surgery program at Northwestern University.  He obtained his medical degree from the University of Illinois College of Medicine, and also holds a Master's in Health Services and Outcomes Research at Northwestern.    Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

On Episode 18 of the Stroke Alert Podcast, host Dr. Negar Asdaghi highlights two articles from the July 2022 issue of Stroke: “Impact of Shunting Practice Patterns During Carotid Endarterectomy for Symptomatic Carotid Stenosis” and “Socioeconomic Inequalities in Reperfusion Therapy for Acute Ischemic Stroke.” She also interviews Dr. Magdy Selim about his article “Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial.” Dr. Negar Asdaghi:         Let's start with some questions. 1) Is deferoxamine mesylate yet another failed agent for treatment of patients with intracerebral hemorrhage, or is deferoxamine getting us closer than ever to an approved therapy for this deadly form of stroke? 2) Are different strokes happening to different folks due to their disadvantaged socioeconomic status? 3) And finally, how does a surgeon's personal practice preference to either routinely or selectively use carotid shunting during carotid endarterectomy impact the recurrent risk of stroke or death in patients with symptomatic carotid disease? We'll tackle these questions and a lot more in today's podcast as we continue to cover the cerebrovascular world's latest and greatest because, without a doubt, this is the best in Stroke. Dr. Negar Asdaghi:         Welcome back to the July issue of the Stroke Alert Podcast. My name is Negar Asdaghi. I'm an Associate Professor of Neurology at the University of Miami Miller School of Medicine and your host for the monthly Stroke Alert Podcast. The July 2022 issue of Stroke contains a range of really interesting papers that I'd like to highlight here. As part of our Cochrane Corner articles, giving us short summaries of the long systematic review of a given topic, we have two short articles, one on the issue of local versus general anesthesia for carotid endarterectomy, where we learn that based on the current evidence, there's no convincing difference between local versus general anesthesia in the risk of stroke and death within 30 days after the procedure. In the second Cochrane Corner article, titled "Information Provision for Stroke Survivors and Their Carers," we learn that stroke survivors and their caregivers routinely report dissatisfaction with information provided to them by their clinicians about their condition and how active approaches to information provision is superior to its passive forms in improving patients' involvement in their care, their satisfaction, and, ultimately and not surprisingly, their stroke outcome. Dr. Negar Asdaghi:         As part of our original contributions in this issue of the journal, we have an important paper titled "The Risk of Early Versus Later Rebleeding From Dural AV Fistulas With Cortical Venous Drainage." We are reminded in this paper that cranial dural arteriovenous fistulas are classified based on their venous drainage into those with or those without cortical venous drainage, or CVD. Dural AV fistulas without CVD rarely cause intracranial bleeding, while those with CVD may cause hemorrhage. In this study, the authors show that the risk of rebleeding of dural AV fistulas with CVD presenting with hemorrhage is increased in the first two weeks after ICH, emphasizing the importance of early detection of these malformations by vascular imaging and early treatment of AV fistulas with cortical drainage. This paper is another analysis from the CONDOR registry. Our devoted Stroke Alert listeners recall that we covered this registry in more detail when we interviewed Dr. Amin-Hanjani last October on the outcomes of intracerebral hemorrhage patients found to have dural AV fistulas. I encourage you to review these articles in addition to listening to our podcast today. Dr. Negar Asdaghi:         Later in the podcast, I have the distinct honor of interviewing Dr. Magdy Selim from Harvard Medical School on a critical analysis from i-DEF trial to examine the long-term outcome of patients with ICH who were randomized to receive deferoxamine versus placebo. As an expert in the field of intracerebral hemorrhage and a member of the recently published American Heart Association Guidelines Committee, Dr. Selim was not fazed at all about the neutral results of the trial. "The future of ICH is bright," he says, and in the interview, he tells us why. But first, with these two articles. Dr. Negar Asdaghi:         Since its first reported successful surgery in 1953, carotid endarterectomy, or CEA, has become a common surgical procedure to prevent ischemic stroke in patients with carotid disease. CEA requires a temporary clamping of the carotid artery that is being worked on. During this time, the ipsilateral hemisphere is, of course, dependent on collateral flow from the posterior circulation or from the contralateral anterior circulation to maintain its perfusion pressure. Intraoperatively, various methods are used to monitor cerebral perfusion, and the risk of clamping-induced hypoperfusion is obviously variable for each patient depending on the patient's specific anatomy, their collateral status, and other risk factors. One way to protect the brain against possible clamp-induced ischemia is to do carotid shunting. The problem is that carotid shunting also comes with its own set of risks and problems. There's the risk of causing carotid dissection, embolization of pieces of the plaque during shunt insertion, or the risk of causing air embolism. Dr. Negar Asdaghi:         There are also other shunt-related local complications that should be noted, such as possibility of causing injuries to the cranial nerves or development of neck hematoma related to the more extensive surgical exposure required for shunting. So, it's not surprising that the practice patterns with regards to shunting is quite variable amongst different surgeons. There are surgeons that are considered routine shunters, and those who are considered selective shunters, meaning that the shunt is inserted only in cases with a particular indication. The question is whether the surgeon's preference for shunting can impact the CEA outcomes. In the current issue of the journal, we have an interesting study led by Dr. Randall DeMartino from the Division of Vascular and Endovascular Surgery at Mayo Clinic, Rochester, where the authors look at the impact of shunting practice patterns during carotid endarterectomy on the following post-CEA outcomes: number one, in-hospital stroke and in-hospital death rates, and number two, combined stroke and death in patients with a recent symptomatic carotid disease, that is, carotid stenosis associated with a history of either ipsilateral stroke or TIA within the past 14 days of endarterectomy. Dr. Negar Asdaghi:         So, the data for the study came from the ongoing Vascular Quality Initiative database, which comprises a network of more than 600 North American academic and community hospitals, and collects data on 12 different vascular procedures, one of which is CEA. The study included over 13,000 carotid endarterectomies performed from 2010 to 2019 for symptomatic carotid patients. This number came after they applied their exclusion criteria to all CEAs performed in the database during this timeframe, importantly excluding any asymptomatic carotid surgeries or those in whom surgery was performed after the two-week mark post qualifying TIA or stroke. Now, before we go over the results, let's go over some definitions used in the study. They had to classify surgeons to be able to do the study into two categories of routine versus selective shunters. So, what they did was to analyze all consecutive CEAs, whether they were done on symptomatic or asymptomatic carotids, in this database, aggregated at the surgeon level. Surgeons routinely shunting in over 95% of their procedures were gauged as routine shunters. Otherwise, they were classified as selective shunters. Dr. Negar Asdaghi:         Now, coming to each case included in this study, each surgical case was, in turn, classified into four categories based on whether or not a shunt was actually used for that particular case: category one, no shunt used; category two, shunt used as a routine procedure; number three, shunt used for a preoperative, mostly anatomical indication; number four, shunt was used for an intraoperative indication, which, as we mentioned before, these are mostly intraoperative hemodynamic compromised situations. And here are the results: In total, 3,186 of surgeries, that is 24% of surgeries, were performed by routine shunters versus 76% by selective shunters. So, most surgeons were selective shunters in this study. The demographic of patients operated by the routine versus selective shunters were more or less similar with regards to the age of the patients, most of their vascular risk factors, and the degree of ipsilateral or contralateral carotid stenosis or occlusion, with a few notable exceptions, in that patients undergoing surgery by routine shunters were more likely White, more likely to have had a prior CABG, more likely to undergo the operation while taking a P2Y12 inhibitor antiplatelet agent, and these patients were more likely to have had a TIA rather than a stroke as their qualifying event, which probably explains why they were more likely to be operated on within 48 hours of symptom onset as well. So, the authors accounted for these differences when they did their multivariate analysis. Dr. Negar Asdaghi:         The other thing to note was that overall, routine shunters used a shunt in 98.1% of their cases, whereas selective shunters used them in 46% of their cases. Now, in terms of their study outcomes, the shunting practice pattern did not impact the primary outcomes of in-hospital stroke or death, or a combination of these two outcomes, or even the odds of development of cranial nerve injuries or hemorrhage in the adjusted model, which is really good news here. But interestingly, in the final adjusted model, whether or not an actual shunt was placed during surgery did significantly increase the risk of postoperative stroke, with the odds ratio of 1.29, an effect that was entirely driven by the use of shunt by a surgeon classified as a selective shunter in this study. Dr. Negar Asdaghi:         So, in simple terms, if a shunt was placed during CEA, it did increase the risk of stroke only if that surgeon was a selective shunter. Another interesting association was that amongst selective shunters, placing a shunt for a patient with a very recent ischemic event, that is, TIA or stroke within the past 48 hours prior to surgery, and placing a shunt for an intraoperative indication, meaning shunt placement was not pre-surgically planned, also significantly increased the risk of postoperative stroke. So, what we learned from the study is that, though a surgeon's shunting practice pattern did not have an impact on the overall postoperative risk of stroke or death, the placement of a shunt did indeed increase the risk of postoperative stroke only if it was placed by a surgeon who is a selective shunter, especially for an intraoperative indication in a patient with a recent ischemic event. Dr. Negar Asdaghi:         So, shunts can be tricky, especially if they're done by a surgeon who doesn't place them routinely. So, my take-home message is that ultimately, like every other procedure in medicine, clinical outcomes are as much operator dependent as they are patient dependent, and for every procedure, it's fair to say that practice makes perfect. Dr. Negar Asdaghi:         It is now more than 25 years since intravenous thrombolytic therapy has been approved for treatment of patients with acute ischemic stroke and more than seven years since randomized control trials demonstrated the efficacy of mechanical thrombectomy to improve clinical outcome in ischemic stroke patients with large vessel occlusions. To date, reperfusion therapies are the only available acute treatments for select patients with ischemic stroke. What do we mean by "select"? "Select" meaning that not all patients will benefit from these therapies, making it absolutely necessary for clinicians to be up to date with various indications and contraindications to use these therapies. Needless to say that the criteria for reperfusion therapies do not and should not consider the socioeconomic status of patients, but sadly, socioeconomic inequalities seem to impact the use of reperfusion therapies. Dr. Negar Asdaghi:         In this issue of the journal, in the study titled "Socioeconomic Inequalities in Reperfusion Therapy for Acute Ischemic Stroke," Dr. Øgendahl Buus from Aarhus University Hospital in Denmark and colleagues studied the impact of the socioeconomic status of stroke patients on the odds of receiving reperfusion therapies in the large nationwide Danish Stroke Registry, or DSR. Now a bit about the registry: DSR contains prospectively collected nationwide data on all stroke patients admitted to Danish hospitals. It's interesting to note that in Denmark, stroke patients are exclusively admitted to public hospitals, and all departments treating stroke patients are obligated to report data to DSR. Now, for this study, they included over 63,000 stroke patients from 2013 to 2018. After excluding hemorrhagic stroke, TIAs, and other exclusion criteria of the study, they arrived at their sample size of 37,187 patients that were included in this study. Dr. Negar Asdaghi:         Now, a few definitions. The socioeconomic status of each patient was determined based on three parameters. Parameter number one, their educational level. It was categorized into three levels of low, medium, or high levels of education. Category number two, income level. This was calculated based on the average family equivalent disposable income, or FED income, during five years prior to stroke onset, again classified into three categories of high, medium, or low income. And the third factor was the employment status of the patient during the calendar year prior to the stroke onset, also categorized into three categories of employed, unemployed, and retired. And, of course, the authors used various definitions to be able to fit special situations into these categories. For instance, a person who is temporarily unemployed due to illness or other special situation was still categorized under the employed category. So, that gave them, in total, nine groups to analyze across these three categories. Dr. Negar Asdaghi:         And here are their findings. The median age of total stroke patients in the cohort was 73.2 years, 44.1% were women, 41% categorized under low educational level, 68% retired, and 33.3% had low income levels. Not surprisingly, patients and hospital characteristics varied tremendously across these nine groups of education, employment, and income, and a univariate analysis in general, low socioeconomic status was associated with more severe strokes, living alone, living at an assisted living residency, having had prior stroke, high comorbidity index score, hypertension, and late hospital arrival. So, they accounted for these differences in their multivariate analysis. Dr. Negar Asdaghi:         Now, overall, the treatment rates of IV thrombolysis was 17.6%, which is actually considered a very high percentage as compared to other registry-based studies, but the percentage of IV thrombolytic use dramatically varied based on the different socioeconomic designation. So, let's look at this. In the univariate analysis, for education, intravenous thrombolysis rates were 19.3% among patients with high educational level compared to 16.2% among patients with low educational level. Let's look at income. For income, IV thrombolytic treatment rates reach 20.7% for high-income patients compared to 14.8% for low-income patients. For employment status, thrombolytic rates were 23.7% among employed patients compared to 15.7% for unemployed patients. In their fully adjusted models, unemployed patients were less likely to receive IV lytics as compared to their employed counterparts. Dr. Negar Asdaghi:         Now, for thrombectomy, socioeconomic gradients were also noted for these three categories. For education, thrombectomy rates were 4.5% among patients with high education level compared to 3.6% among patients with low educational level. For income, treatment rates were 3.2% among low-income patients compared to 4.7% among high-income patients. But arguably, the most robust differences were noted again across the category of employment. Employed patients were nearly twice more likely to receive thrombectomy as compared to unemployed patients, rates being 5.1% versus 2.8%, respectively. Now, when they adjusted their analysis to only those patients presenting within the reperfusion time windows in the fully adjusted models, unemployment and low income remain significant negative predictors of receiving both of these reperfusion therapies. So, what we learned from this study is that stroke patients who were unemployed, earned a relatively low income, or had fewer years of formal education were less likely to receive life-saving reperfusion therapies despite potentially being eligible for these treatments. Dr. Negar Asdaghi:         Now, let's take a moment to really understand that data presented here are in the context of a tax-funded, universal healthcare offered across Denmark, where we can at least make the assumption that financial constraints potentially preventing access to therapies are likely minimized. There are many countries around the globe where patients or family members have to pay for these therapies before even receiving them. So, these findings from the current study from Denmark are alarming in that they point to possibly more robust inequalities across the globe in other healthcare systems. Dr. Negar Asdaghi:         Intracerebral hemorrhage, or ICH, is an aggressive form of stroke, typically carrying a higher morbidity and mortality than its ischemic counterpart. Yet much of the research in the field of intracerebral hemorrhage has followed the ischemic stroke footsteps, including defining the optimal primary outcome for the randomized trials of ICH. For ischemic stroke, the 90-day functional outcome, as measured by the modified Rankin Scale, is commonly used as a primary outcome in clinical trials. There are many reasons for this selection, including the ease of use and the fact that the majority of functional recovery post-ischemic stroke occurs during the first 90-day time period. But time to maximum recovery and, importantly, the trajectory of recovery may be different in hemorrhagic as compared to ischemic stroke. Defining the long-term outcomes and longitudinal trajectory of recovery in ICH is, therefore, important to better understand its prognosis and, of course, selecting the appropriate primary outcome measure for future randomized trials of ICH. Dr. Negar Asdaghi:         In the recent years, the safety and efficacy of various agents to improve ICH outcomes have been tested. Deferoxamine mesylate, an iron-chelating agent, is one such agent that was recently studied as part of the i-DEF multicenter randomized trial, and the main results of the study were published in Lancet Neurology in 2019. In the current issue of the journal, in the study titled "Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage," we learn about the results of a post hoc analysis of i-DEF that looks at the trajectory of functional outcome in patients enrolled in the trial with a special attention on their continued recovery after the 90-day post-ICH mark. Dr. Negar Asdaghi:         Joining me now is the senior author of this paper, Dr. Magdy Selim, who's also one of the primary investigators of i-DEF trial. Dr. Selim is a Professor of Neurology at Harvard Medical School and Chief of Stroke Division at Beth Israel Deaconess Medical Center in Boston. He's a world renowned researcher in the field of cerebrovascular disorders with special focus on treatment of patients with intracerebral hemorrhage. Dr. Selim has led and currently leads multiple National Institutes of Health-funded clinical trials of intracerebral hemorrhage, including the ongoing SATURN trial. I'm delighted to welcome him to our podcast today. Good afternoon, Magdy. Thank you for joining us today. Dr. Magdy Selim:             Thank you, Dr. Asdaghi. It's really my pleasure to be here with you, and I'm certainly honored to do this today. Dr. Negar Asdaghi:         That's great. Thank you. So, let's start with some background on deferoxamine and the literature supporting the use of deferoxamine before i-DEF. Dr. Magdy Selim:             So, as you mentioned, deferoxamine is an iron chelator; it binds to iron and removes excess iron from the body. The unique thing about it is that it has other neuroprotective properties, which are good for hemorrhagic stroke and ischemic stroke. It also has anti-inflammatory and anti-apoptotic effects. It even lowers the blood pressure, which we know sometimes is helpful in intracerebral hemorrhage. The rationale behind this or why this would be effective really comes from animal studies. After you have a hemorrhage, there is hemolysis of the red blood cells, there is a release of hemoglobin degradation products, in particular, iron, and the accumulation of iron in the hematoma and the surrounding tissue triggers a cascade of molecular and cellular events that lead to what we call secondary injury, characterized by inflammation, hydroxyl radical formation, and cell death. And many animal studies, animal models of intracerebral hemorrhage, whether in pigs or in rats, young or aged rats, have shown that treatment with deferoxamine can reduce iron in the brain after intracerebral hemorrhage and also results in improved performance on behavioral tests. And that was the reason why we moved into clinical testing. Dr. Negar Asdaghi:         So, a lot of encouraging data before the trial. Can we hear a little bit about the trial, its design, and inclusion criteria, please? Dr. Magdy Selim:             Sure. So i-DEF was a phase 2 study, and actually it started as Hi-DEF, which was high dose deferoxamine, and then became i-DEF, which intermediate dose deferoxamine. So, it's a randomized, double blind, placebo control trial. We used something called futility design, which is actually sort of new in the stroke field. And we had 294 patients who had supratentorial hemorrhage that were randomized within 24 hours to either get placebo or deferoxamine. And deferoxamine initially was given at 62 mg per day for three days, but then we ran into some safety issues with this high dose, and that's why we lowered it to 32, and that became the intermediate dose, or the i-DEF. So, the only kind of thing unique about inclusion/exclusion criteria was that there was an age cutoff, patients had to be 80 or younger. They needed to have some deficit on the exam, so their NIH Stroke Scale had to be 6 or greater, and their GCS had to be greater than 6, and their modified Rankin before the onset of the hemorrhage had to be less than 1. Dr. Negar Asdaghi:         And so, what were the primary and secondary outcomes in i-DEF? Dr. Magdy Selim:             The primary outcome was twofold actually. One of them was safety. One of the issues we ran into with the high dose is that the drug is associated with increased risk for adult respiratory distress syndrome, ARDS. So, we wanted to make sure that this lower dose was safe, and it does not increase the instance of ARDS. The second thing was, as I said, we used something called the futility design, and we wanted to compare the outcome of patients treated with deferoxamine versus placebo to determine whether it's futile to move to a large phase 3 trial or not. And what we were looking at is a difference in outcome and modified Rankin 0 to 2 at 90 days, and the difference would be at least 12% in favor of deferoxamine in order for us to move forward. You asked about the secondary outcomes as well? Dr. Negar Asdaghi:         Yes. Dr. Magdy Selim:             So, actually, the secondary outcomes, they're relevant because they're relevant to the study that we just published. So, the secondary outcomes was also to look at modified Rankin 0 to 3, instead of 0 to 2, at 90 days and the difference between the two treatment groups. We wanted to look at the ordinal distribution of the Rankin at the same time point. And we also wanted to look at all the outcomes at six months, 180 days. And that came a little bit later in the course of the study because there was some evidence emerging at that time that maybe assessment of outcome later in intracerebral hemorrhage would be more accurate than assessing it early on. Dr. Negar Asdaghi:         So, I want to come back to the secondary outcome, of course, that's sort of the topic of your current paper in this issue of the journal, but can you just briefly tell us, please, the primary outcome and the sort of results of what was published in 2019 with i-DEF before we move on to the current paper? Dr. Magdy Selim:             Yeah. So, as I said, the primary outcome was the difference in the proportion of patients that achieved modified Rankin 0 to 2 at 90 days, and what we wanted to see is a difference of around 12%. Unfortunately, the primary outcome was neutral, we did not see that. But what we saw actually, almost all the secondary outcomes were positive, except for the primary outcome. So, when we looked at the secondary outcome using modified Rankin 0 to 3, instead of 0 to 2, the difference was 12.1%. When we looked at the difference in the modified Rankin 0 to 2 at six months, the difference was 15.6% in favor of deferoxamine, but these were secondary outcomes and not the primary outcomes. Dr. Negar Asdaghi:         So, the trial is almost positive. It just depends on how you define the primary outcome, which is really a nice segue to your current study. In the current study, you looked at this secondary outcome in a longitudinal way and looked at the mRS of 0 to 2 at six months from ICH. Can you please tell us about this current paper? Dr. Magdy Selim:             Yeah. So, one of the things that we did with i-DEF is that we were checking the modified Rankin at different time points for all the patients. So, we had it after one week, after one month, after two months, after three months, and after six months. And what we wanted really was a couple of things, just in patients with intracerebral hemorrhage without any treatment, what's the natural course of recovery? And the interesting thing we found out is that patients actually continue to improve over time, and that's what you expect, but what we didn't expect is that they even continue to improve after 90 days. Dr. Magdy Selim:             We always used to think that maximum recovery is around 90 days from ischemic stroke literature, but we saw a lot of patients getting better after 90 days. And this turns out to be also the case with deferoxamine, but the interesting thing is that the percentage of patients that had a good outcome, modified Rankin 0 to 2, was higher with deferoxamine at day seven, at day 30, at day 60, not at 90 days, but again at six months. So, actually, it was higher at all time points except our primary endpoint. Dr. Negar Asdaghi:         So, Magdy, you've already answered my next question, which is exactly what you alluded to, deferoxamine seemed to have improved the outcomes at all of those time points, except for the 90 day, which was the primary outcome of your trial. Why do you think the magic was lost at 90 days? Dr. Magdy Selim:             This is really the million-dollar question. I think we obviously struggled over this. And we went back, we thought maybe there was misrating of the modified Rankin in some of the patients. We tried to correct for this. The difference was bigger, but still not significant. So, we don't really have a good reason to tell you why, at this particular time point, we didn't see the difference except bad luck, I think. But I mean, there are reasons, I think, the question that people actually ask me is the opposite, is why do you think a drug that you give for three days early on is going to make a difference after six months? And I think there are biological reasons to explain this. Dr. Magdy Selim:             So, what happened is that those hemorrhage patients have a lot of other problems. They have increased ICP, they have hydrocephalus, they have intraventricular hemorrhage, and actually iron has been implicated in the development of hydrocephalus in chronic white matter injury. So, my explanation is that you start early on with the treatment, it does help, but it takes a while for it to kick in and for this kind of medical complication to resolve until actually you see the true effect of the drug. And maybe that's why you see the unmasking at the end between the two groups. Dr. Negar Asdaghi:         Yeah, I think I want to recap this for our listeners. Very important to, again, think about those things that some of the acute therapies that we offer the patients may not have a measurable improvement outcome difference early on, certainly with intravenous thrombolysis, we saw that, whereas we saw measurable outcome difference at 90 days, or maybe in this case at six months, but not quite early on. So, it doesn't mean that they don't work. We just are unable to measure that difference and improvement early on. So, what do you think the future holds for deferoxamine? Are we going to see another trial? Dr. Magdy Selim:             Well, I certainly hope so. We're working on some few ideas for that. A lot of people think that maybe we should just do the same thing, but look at six months as the primary outcome. But I think we're actually, that's probably not our primary thinking at this point in time. So, we have published other papers, other analysis, to show that the effect of deferoxamine actually relates to the volume of the hemorrhage. So, if the hemorrhage is very small, there is very minimal benefit. If the hemorrhage is very large, also there is very minimal benefit. And that's really to get kind of the big bang for your buck. You really want people who have mild-to-moderate size hemorrhages. So, we're thinking of a couple of ways to go about deferoxamine with this, whether alone or in combination with other interventions. So, hopefully, we'll have some stuff to share with you in the coming few years, two or three. Dr. Negar Asdaghi:         We'll definitely look forward to reading about those or being involved in the trials as a site, but there's a great way of just actually talking about my next question. It's just completely different than the current paper. I wanted to digress a bit and talk about the recently published intracerebral hemorrhage guidelines, which just published a few months ago. You were part of the guidelines committee. Can you give us a little bit of your point of view of what are the top two most important updates from the guidelines in ICH treatment? Dr. Magdy Selim:             Actually, the guidelines, for the first time this year, in the first page, they have the top 10 take-home messages or top 10 new ones. So, in my opinion, the most important ones, we usually tell you what to do, but here we tell you what not to do because we think it's not good for the patients. So, for example, using steroids just as a prophylactic therapy is actually not recommended. The same thing, we see a lot of people put patients with hemorrhage on hypertonic saline, hyperosmolar therapy, just prophylactically. I don't think there's any benefit that this helps as well, and the same thing for antiepileptic drugs. So, that was one important point. The second one was blood pressure lowering, and there is emphasis now that whatever you use to lower the blood pressure, you want to make sure that the blood pressure variability is very minimal and that there is a smooth kind of control over blood pressure that has been shown to be actually important in terms of help. I'm going to make them three, not two, because I think the third one is important. Dr. Negar Asdaghi:         Okay. I'll give you one more then. Dr. Magdy Selim:             Which is the first time we include this in the guideline, and with emphasis on the role of the home caregiver for hemorrhage patients and the psychological support, the education that they need, and the training that they need to actually care for these patients and how to improve their quality of life. So, I think that's an important aspect that we didn't touch upon before, and obviously very important. Dr. Negar Asdaghi:         Very important points. Let me just review them again for our listeners. So, don't do steroids, hypertonics, and preemptive antiepileptic therapies. They don't work. The second point that you raise is reduction of blood pressure, important to keep that in mind, but paying attention to blood pressure variability. And the third one, the importance of social aspect of care of patients with intracerebral hemorrhage. That's great for us. Let me just end with one last question. Magdy, thank you so much for all of this wonderful take-home messages from the current study from i-DEF and also the guidelines. There's been a lot of excitement in the field of ischemic stroke with the success of reperfusion therapies, and yet not much for intracerebral hemorrhage. What is your hope in terms of future therapies for ICH? Dr. Magdy Selim:             So, I happen to be one of the people who is very optimistic about the future of ICH. I think it's just a matter of time. But I think we need to make some changes. We need to really treat ICH as an emergency, so time is really important. And I think right now, you see a hemorrhage patient, they just put them on the side because they think that there's nothing to do. But the way I see the future evolving, and probably the breaking point to be, is that we can diagnose ICH in the field. You immediately lower the blood pressure, reverse coagulopathy if you can, and even kind of use hemostatic agents, if the FASTEST trial shows evidence to support that, and then you take them to the hospital where there might be some role for hematoma reduction using minimally invasive therapy and some other treatments like deferoxamine, or there are a lot of other agents to target the secondary injury at the same time. So, I think it's going to be a combination of things, and they need to happen in tandem and continuously, but we need to start quickly on these patients. Dr. Negar Asdaghi:         Dr. Magdy Selim, it's been a pleasure interviewing you on the podcast. We look forward to having you back and covering more of your work. Thank you for joining us. Dr. Magdy Selim:             Thank you very much for having me. Dr. Negar Asdaghi:         And this concludes our podcast for the July 2022 issue of Stroke. Please be sure to check out this month's table of contents for a full list of publications, including a series of Focus Updates on the very topic of, you guessed it, intracerebral hemorrhage. These updates are great complements to the newly published American Heart Association guidelines for the management of patients with spontaneous intracerebral hemorrhage in May 2022. Dr. Negar Asdaghi:         And with this, we end our July podcast and draw inspiration from one particular July story, which unfolded on July 20. In 1969, on this day, Commander Neil Armstrong and lunar module pilot Buzz Aldrin landed on the moon, and Armstrong became the first person to walk on the moon. The crew of Apollo 11 changed the course of history, landing humanity on another celestial body for the first time and later safely returning everyone back to earth. Armstrong, an experienced naval aviator, a test pilot, a decorated veteran, astronaut, and university professor, passed away in 2012 from complications of coronary artery disease, reminding us that every step we take in understanding, diagnosing, and treating vascular disorders is truly part of that giant leap to save the mankind. And what better way to do this than to stay alert with Stroke Alert. Dr. Negar Asdaghi:         This program is copyright of the American Heart Association, 2022. The opinions expressed by speakers in this podcast are their own and not necessarily those of the editors or of the American Heart Association. For more, visit AHAjournals.org.

In this weeks episode, we are joined by Dr Leonard Shan. A vascular surgeon working at St Vincent's hospital in Melbourne. Dr Shan is currently completing a PhD through the University of Melbourne, and joins us to talk today about balancing his busy research career, with his professional career and his home life. Dr Shan is an academic vascular surgeon and honorary senior fellow in the Department of Surgery at The University of Melbourne. He received his medical education at The University of Melbourne where he graduated with honours. Following vascular surgical training at multiple centres in Melbourne and Auckland, he joined the vascular staff at St. Vincent's Hospital in 2020.His academic interest is in outcomes research where he has helped to improve the understanding of patient- reported outcomes after intervention. He serves on the editorial board of the Annals of Vascular Surgery and is a regular reviewer for the European Journal of Vascular and Endovascular Surgery and the Journal of Vascular Surgery. Leonard is currently undertaking a PhD on the patient-reported outcomes and economic evaluation of arterial surgery with Professor Peter Choong at The University of Melbourne, where he is the recipient of an Australian Government Research Training Program scholarship.

We are very excited to have Dr. Kellie Brown, the current Vice-Chair of the Vascular Surgery Board, and Dr. Malachi Sheahan, the Vice-Chair Elect, to pull back the curtain on how the VSB serves the public and the vascular surgery community at large while defining our specialty. They discuss the history of the VSB, provide some insight into board examination development, and clarify the process of Continuous Certification Assessment. They also discuss the new nomination process adopted this year by the VSB, and how interested people can get more involved.    Dr. Kellie Brown is Professor of Surgery and Radiology in the Division of Vascular and Endovascular Surgery at The Medical College of Wisconsin, and the Chief of Vascular Surgery at the Zablocki VA Medical Center. She is the Program Director for the Vascular Surgery Fellowship at the Medical College of Wisconsin.    Dr. Malachi Sheahan is Professor of Surgery and Chair of Vascular and Endovascular Surgery and Program Director for the Vascular Surgery Integrated Residency and Fellowship at LSU Health Sciences Center in New Orleans.    Vascular Surgery Continuous Certification Assessment VSB Update - Spring 2021 What other topics would you like to hear about? Let us know more about you and what you think of our podcast through our Listener Survey or email us at AudibleBleeding@vascularsociety.org. Follow us on Twitter @audiblebleeding   Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

The Society for Vascular Surgery was founded on July 3rd, 1946 at the Fairmount Hotel in San Francisco, California by thirty-one vascular surgeons looking to improve the field. In August 2021, the SVS kicked off a year-long celebration of its 75th anniversary. As part of this celebration, the SVS Foundation will be hosting the "Cheers to 75 Years Gala" in Boston on June 17th. This fundraiser will allow the SVS Foundation to make even greater progress in accomplishing its mission of optimizing the vascular health and well-being of patients and the public through support of research.    To discuss the upcoming gala and the SVS Foundation, we have three guests with us today:    Dr. Ronald Dalman, MD, DFSVS, Past President of the SVS, is here with us today in his role as Chair of the Gala Committee. @RLDalmanMD   Dr. Venita Chandra is an Associate Professor of Surgery and the Program Director for the vascular surgery fellowship at Stanford.  She is here today in her role as co-Chair of the Gala Committee. @ChandraVenita   Dr. Peter Lawrence is Wiley Barker Professor and Chief of the Division of Vascular and Endovascular Surgery at UCLA and Senior Editor of the Journal of Vascular Surgery.  He joins us today in his role as the Chair of the SVS Foundation.   Listen to the SVS Foundation episode, April 3rd, 2021 Listen to the VISTA Program episode, May 3rd, 2021    Want to donate to the auction? Contact Rupa Brosseau at rbrosseau@vascularsociety.org   What other topics would you like to hear about? Let us know more about you and what you think of our podcast through our Listener Survey or email us at AudibleBleeding@vascularsociety.org. Follow us on Twitter @audiblebleeding   Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

A client has nutcracker syndrome, and she is not a good candidate for surgical correction. She wants massage to help deal with her symptoms. But nutcracker syndrome is a kidney problem with a risk of thrombosis and renal damage. Yikes! Can massage be safe? As always, it depends. Listen in to see what it depends on.    Sponsors:     Anatomy Trains: www.anatomytrains.com      Books of Discovery: www.booksofdiscovery.com       Host Bio:                    Ruth Werner is a former massage therapist, a writer, and an NCBTMB-approved continuing education provider. She wrote A Massage Therapist's Guide to Pathology, now in its seventh edition, which is used in massage schools worldwide. Werner is also a long-time Massage & Bodywork columnist, most notably of the Pathology Perspectives column. Werner is also ABMP's partner on Pocket Pathology, a web-based app and quick reference program that puts key information for nearly 200 common pathologies at your fingertips. Werner's books are available at www.booksofdiscovery.com. And more information about her is available at www.ruthwerner.com.                                     Recent Articles by Ruth:          “Unpacking the Long Haul,” Massage & Bodywork magazine, January/February 2022, page 35, www.massageandbodyworkdigital.com/i/1439667-january-february-2022/36.   “Chemotherapy-Induced Peripheral Neuropathy and Massage Therapy,” Massage & Bodywork magazine, September/October 2021, page 33, http://www.massageandbodyworkdigital.com/i/1402696-september-october-2021/34.           “Pharmacology Basics for Massage Therapists,” Massage & Bodywork magazine, July/August 2021, page 32, www.massageandbodyworkdigital.com/i/1384577-july-august-2021/34.        Resources:    Pocket Pathology: https://www.abmp.com/abmp-pocket-pathology-app   Ananthan, K., Onida, S. and Davies, A.H. (2017) ‘Nutcracker Syndrome: An Update on Current Diagnostic Criteria and Management Guidelines', European Journal of Vascular and Endovascular Surgery, 53(6), pp. 886–894. doi:10.1016/j.ejvs.2017.02.015.   Kurklinsky, A.K. and Rooke, T.W. (2010) ‘Nutcracker Phenomenon and Nutcracker Syndrome', Mayo Clinic Proceedings, 85(6), pp. 552–559. doi:10.4065/mcp.2009.0586.   Renal Nutcracker Syndrome: Symptoms, Causes, and Treatment (2018) Healthline. Available at: https://www.healthline.com/health/nutcracker-syndrome (Accessed: 14 February 2022).   About our sponsors:   Anatomy Trains is a global leader in online anatomy education and also provides in-classroom certification programs for structural integration in the US, Canada, Australia, Europe, Japan, and China, as well as fresh-tissue cadaver dissection labs and weekend courses. The work of Anatomy Trains originated with founder Tom Myers, who mapped the human body into 13 myofascial meridians in his original book, currently in its fourth edition and translated into 12 languages. The principles of Anatomy Trains are used by osteopaths, physical therapists, bodyworkers, massage therapists, personal trainers, yoga, Pilates, Gyrotonics, and other body-minded manual therapists and movement professionals. Anatomy Trains inspires these practitioners to work with holistic anatomy in treating system-wide patterns to provide improved client outcomes in terms of structure and function.      Website: anatomytrains.com           Email: info@anatomytrains.com          Facebook: facebook.com/AnatomyTrains     Instagram: instagram.com/anatomytrainsofficial        YouTube: www.youtube.com/channel/UC2g6TOEFrX4b-CigknssKHA           

Due to its two-dimensional (2D) nature and the high radiation exposure associated with its use, fluoroscopy is an imperfect solution to endovascular surgery's need for intraoperative imaging. Adam Beck, MD discusses non-fluoroscopic imaging for endovascular surgery

Tweet out this episode! Bio* Dr. Megan Tracci, MD, JD, is a member of the Division of Vascular and Endovascular Surgery, as well as the medical director of the inpatient vascular unit and co-director of the multidisciplinary Vein Clinic at UVA Health. She completed her graduate training at the University of Illinois where she received a dual MD/JD degree with a focus on health policy and patient safety. Dr. Tracci has been a member of the UVA community since 2001 and completed her surgical training in both general and vascular surgery at UVA before joining the faculty in 2010. Her clinical and academic interests include the open surgical and endovascular treatment of aortic and peripheral vascular disease, the management of venous disorders and functional outcomes following surgery. Beats: Jaze Beats by John Echols Podcast Edit: Tylor Klipfel * via UVA Health website

This year marks the 75th Anniversary of the Society for Vascular Surgery. This year's Vascular Annual Meeting will also be a very welcome return to in-person meetings after the pandemic.  Sharif and Fanny chat with the co-Chairs of the Program Committee for the VAM, Dr. Andy Schanzer and Dr. Matt Eagleton, to give us a preview. Dr. Andres Schanzer is a Professor of Surgery and Chief of the Division of Vascular and Endovascular Surgery at the University of Massachusetts Memorial Medical Center and University of Massachusetts Medical School in Worcester, Massachusetts, with a secondary appointment as Professor of Quantitative Health Sciences.  He serves as the Director of the UMass Memorial Heart and Vascular Center and is the founding Director of the UMass Memorial Center for Complex Aortic Disease. He serves as the national principal investigator for the United States Fenestrated and Branched Endograft Research Consortium. This is his first year as co-Chair of the Program Committee for the Vascular Annual Meeting of the Society for Vascular Surgery. Dr. Matthew Eagleton is the chief of the Division of Vascular and Endovascular Surgery at Massachusetts General Hospital and co-director of the Fireman Vascular Center  leading a multi-disciplinary team interested in the management of vascular disease. Dr. Eagleton's clinical and research interests are focused on the pathobiology and endovascular treatment options for complex aortic disease. Dr. Eagleton has served in a variety of national organizations including the Vascular and Endovascular Surgical Society and the Society for Vascular Surgery. This year, he is completing his tenure as Chair of the Program Committee for the Vascular Annual Meeting of the Society for Vascular Surgery. Dr. Fanny Alie-Cusson is joining us today for her first interview as part of the Audible Bleeding family. She is an Assistant Professor of Vascular Surgery at the University of Pittsburgh Medical Center. Click here to register for VAM21 See the VAM21 program here What other topics would you like to hear about? Let us know more about you and what you think of our podcast through our Listener Survey or email us at AudibleBleeding@vascularsociety.org. Follow us on Twitter @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

Kreutzburg T. et al. Editor's Choice - The GermanVasc Score: A Pragmatic Risk Score Predicts Five Year Amputation Free Survival in Patients with Peripheral Arterial Occlusive Disease. European Journal of Vascular and Endovascular Surgery. Febrero 2021, 61(2);248-256 DOI: https://doi.org/10.1016/j.ejvs.2020.11.013 Anfitriones: - Dr. Rodrigo Garza Herrera - Dra. Nora Lecuona - Dra Davinia Sámano (01:00) Metodología (04:00) Descripción de los resultados (05:50) Descripción del score de riesgo (07:35) Epidemiología en México (12:30) Importancia de aplicar el GarmanVasc Risk Score en la práctica diaria (15:00) Análisis del Score (20:30) Conclusiones

Rachael and Francesca discuss with Mr. Jonathan Boyle and Aminder vascular surgery registries in the UK, how they contribute to device safety and lessons learned from the Nellix experience. Mr. Jonathan Boyle MD FRCS graduated from the University of Leicester in 1991, completed a Doctor of Medicine postgraduate research degree in 2000, and was appointed as a consultant vascular surgeon in Cambridge University Hospitals NHS Trust in 2002, where he was Clinical Lead for Vascular Surgery from 2014-17. He has held numerous national and international leadership roles.  Amongst others, he is Vice President of the Vascular Society of Great Britain and Ireland (VSGBI), Past President of the British Society for Endovascular Therapy, and Section Editor of the European Journal of Vascular and Endovascular Surgery. During his roles as Clinical Lead for the UK’s National Vascular Registry (NVR) and Chair of the VSGBI Audit and Quality Improvement Committee, he led the development of the Peripheral Artery Disease Quality Improvement Framework and, more recently, has introduced the incorporation of device-specific information into the NVR.  Under his leadership, the NVR team won the HQIP Team of the Year 2020 award in recognition of their “outstanding work on registry device capture, quality improvement and a rapid response to COVID-19”.  He has also worked closely with Medicines and Healthcare products Regulatory Agency on failing vascular devices. Aminder Singh MBBS is an Academic Clinical Fellow at the University of Cambridge and vascular surgery specialty trainee in the East of England, currently undertaking research investigating the development of stem cell models to characterize aortopathy variants.  He is the venous and European rep on the Rouleaux Club Executive Committee. Co-host: Francesca Guest MBChB is a vascular surgery specialty trainee on the South West England training program, currently working in Exeter.  She is the Association for Surgeons in Training (ASiT) rep on the Rouleaux Club Executive Committee. Resources: UK Vascular Services Quality Improvement Programme (including the National Vascular Registry): https://www.vsqip.org.uk Vascular Society of Great Britain and Ireland: https://www.vascularsociety.org.uk UK National Joint Registry: https://www.njrcentre.org.uk/njrcentre/ British Society for Endovascular Therapy: https://www.bset.co.uk Relevant papers: Singh AA, Benaragama KS, Pope T, Coughlin PA, Winterbottom AP, Harrison SC, Boyle JR. Progressive Device Failure at Long Term Follow Up of the Nellix EndoVascular Aneurysm Sealing (EVAS) System. Eur J Vasc Endovasc Surg. 2021 Feb;61(2):211-218. doi: 10.1016/j.ejvs.2020.11.004. Epub 2020 Dec 7 Singh AA, Boyle JR. Introduction of New Medical Devices: Lessons Learned From Experience With Endovascular Aneurysm Sealing. J Endovasc Ther. 2020 Feb;27(1):160-162. Singh AA, Boyle JR. Readmission and Re-intervention are Better Measures of EVAR Quality. Eur J Vasc Endovasc Surg. 2020 Oct;60(4):518. doi: 10.1016/j.ejvs.2020.08.011

Adam, Robin, and Dr. Forbes sit down with Drs Lawrence, Nelson, and Eldrep-Jorgensen to discuss the Society for Vascular Surgery Foundation and introduce one of its newest initiatives, the VISTA program. Peter Lawrence, MD is Wiley Barker Professor and Chief of the Division of Vascular and Endovascular Surgery at UCLA and senior editor of the Journal of Vascular Surgery.  He joins us today in his role as the Chair of the SVS Foundation. Peter Nelson, MD (@prn19) is the Professor and Chief of Vascular Surgery, Mary Louise Todd Chair in Cardiovascular Research, OU College of Medicine, and Chair of the Foundation Development Committee of the SVS Foundation. Jens Eldrup-Jorgensen, MD is a professor of surgery at Tufts University and Maine Medical Center and medical director for the Society of Vascular Surgery for the Vascular Quality Initiative. He is the innovative force behind the development of the Vascular Volunteers Improve Service to All Program, also known as VISTA. Donate to the SVS Foundation here. Relevant Links: SVS Foundation SVS Foundation 2020 Annual Report Vascular Volunteers Improve Service to All (VISTA) Program Co-host introductions Thomas Forbes, MD (@TL_forbes) is a professor of surgery and RJ Elliot Chair and Division Head of Vascular Surgery at the University of Toronto and was our 4th guest on the podcast and has been a major supporter of our work and will be joining our team more regularly. Robin Osofsky, MD (@OsofskyRobin) s a general surgery resident at University of New Mexico who is interested in applying for vascular surgery. Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.

Dr. Barend Mees joins us to discuss the upcoming 24th European Vascular Course, and how they are adapting surgical simulation to virtual education. Dr. Mees is a consultant Vascular & Endovascular Surgeon in the department of Vascular Surgery at MUMC+ in Maastricht. He currently is Associate Professor and Deputy Head of the department of Vascular Surgery. His clinical area of interest is the endovascular treatment of complex aortic disease and peripheral arterial disease. He is the research coordinator of the department of Vascular Surgery and has obtained a PhD in Vascular Biology from Erasmus MC, INSERM (U689, Paris) and Max-Planck Institute (Bad Nauheim, Germany). His main research focus areas are vascular biology, tissue engineering and training in innovative endovascular techniques.    Dr. Mee is the inventor of the MAZE Box, a novel hands-on training simulator for Endovascular Surgery and tutor for Vascular International. Dr. Mees is an examiner of the UEMS FEBVS examination since 2017. He is organizer of the I-MEET congress and course director of the European Vascular Course. He has been Secretary of the Dutch Society for Vascular Surgery since 2018. European Vascular Course - March 7-8, 2021 Watch the MAZE box in action!   What other topics would you like to hear about? Let us know more about you and what you think of our podcast through our Listener Survey or email us at AudibleBleeding@vascularsociety.org. Follow us on Twitter: @AudibleBleeding

February 17th, 2021 We are very excited to have three guests on the podcast to discuss the new Society for Vascular Surgery Learning Management System.    Dr. Kellie Brown is a Professor of Surgery and Radiology in the Division of Vascular and Endovascular Surgery at The Medical College of Wisconsin and the Chief of Vascular Surgery at the Zablocki VA Medical Center. She is the Program Director for the Vascular Surgery Fellowship at the Medical College of Wisconsin. She is the Chair of the Education Committee for the Society for Vascular Surgery.    Dr. Rabih Chaer is a Professor of Surgery in the Division of Vascular Surgery at the University of Pittsburgh, as well as the Program Director for the Vascular Integrated Residency and the Chief of Vascular Surgery at UPMC Presbyterian. He is the Chair of the Education Council for the Society of Vascular Surgery.   Lisa Cohen is the Director of Education and Professional Development for the Society of Vascular Surgery.  She is currently the Co-Chair of the Medical Specialty Society Section of the Alliance for Continuing Education in the Health Professions. Log on to the SVS Education portal here.    Submit your feedback on the SVS Education portal here: education@vascularsociety.org   What other topics would you like to hear about? Let us know more about you and what you think of our podcast through our Listener Survey or email us at AudibleBleeding@vascularsociety.org.   Follow us on Twitter: @AudibleBleeding

Dr. Yamashita is a Cardiac Surgeon and Assistant Professor at the University of Manitoba, the Director of Complex Thoracic Aortic Surgery, the Surgical Co-Director of Heart Failure – ECMO program, and the Director of the Manitoba Thoracic Aortic Diseases Clinic. He completed medical school at McGill University and Cardiac Surgery residency at the University of British Columbia. Dr. Yamashita completed Fellowships at UBC in Transapical Aortic Valve Replacement and VAD/Transplant, as well as at Northwestern Memorial Hospital in Chicago in Advanced Valve Repair, Minimally Invasive Valve Surgery, Atrial Fibrillation Surgery and VAD/Transplant. Finally, before coming to Winnipeg he completed a one-year Fellowship in Aortic and Endovascular Surgery at the Cleveland Clinic. His research interests include aortic disease, heart failure and outcomes post-cardiac surgery. He has co-authored a number of peer reviewed papers in major journals and has 5 published book chapters. Show notes available at northernexposurepodcast.ca

With the interview season underway amidst a pandemic, we sought out advice for students applying to the integrated vascular surgery residency from three experts.  Dr. Chelsea Dorsey was recently on the podcast discussing recruitment and retention of under-represented minorities at all levels. Dr. Dorsey attended medical school at the University of Chicago Pritzker School of Medicine, and completed an integrated vascular surgery residency at Stanford University.  She serves as Director of Preclinical Advising in the medical school - a role that allows her to have significant facetime with 1st and 2nd year students. Of note, she also serves as Director of the MS3 Surgical Simulation Course and was recently nominated to the Academy of Distinguished Medical Educators at the University. She currently sits on a number of regional and national education committees, including the SVS, COVERS, and MVSS. Dr. Murray Shames (@MurrayShames)  is the current President of the Association for Program Directors in Vascular Surgery, as well as the Division Chief of Vascular Surgery and former Program Director at the University of South Florida. His teaching experience includes developing models for the Fundamentals of Vascular Surgery and Fundamentals of Endovascular Surgery courses. He has been the course Co-Director for the Introduction to Academic Vascular Surgery Course in Tampa since 2012, and has served as an instructor/preceptor to dozens of residents since coming back to USF in 2002.  Dr. Arash Fereydooni (@Arash_Fere) is currently one of the first-year integrated vascular surgery residents at Stanford University. Dr. Fereydooni completed a BS and MS in Molecular, Cellular and Developmental Biology at Yale.  He then received his medical degree in 2020 from Yale School of Medicine where he did a Howard Hughes Medical Institute Fellowship under the mentorship of Dr. Alan Dardik. He currently serves on the Student Education committees of SVS and VESS. In 2019, he started the annual SVS Integrated Vascular Surgery Match webinar.   Nominate someone for the SVS Excellence in Community Service Award! If you enjoy our content, please contribute to Support Audible Bleeding! Help us improve through our Listener Survey! Follow us on Twitter: @AudibleBleeding

The Journal of Vascular Surgery has been piloting online journal clubs and would like to open them up to a broader audience.  Two JVS Editors join us to discuss this innovative approach to critically reviewing impactful research in vascular surgery and how to get involved.   Paul DiMuzio, MD (@pdimuziomd)- Assistant editor of the Journal of Vascular Surgery and the Director of the Division of Vascular and Endovascular Surgery at Jefferson Health in Philadelphia, PA. Misty Humphries, MD (@mhumphriesmd) - on the editorial board of the Journal of Vascular Surgery and Associate Professor of Surgery at UC Davis in Sacramento, CA.   *Click here to sign up to host a monthly journal club in 2021* *Click here to register for the December virtual journal club (Wed 12/16/2020 9pm Eastern on Zoom)* If you enjoy our content, please contribute to Support Audible Bleeding! Help us improve through our Listener Survey! Follow us on Twitter: @AudibleBleeding

November 9th, 2020 Vascular Decision Making: Medical, Endovascular and Surgical     We are excited to interview the editors of the newly released textbook, Vascular Decision Making: Medical, Endovascular and Surgical. They discuss the process of editing a textbook and what makes this resource unique. They also describe the novel app that they have developed to go along with the textbook.     Jack Cronenwett is Emeritus Professor of Surgery at the Dartmouth-Hitchcock Medical Center. He has served as President of the Society for Vascular Surgery and Editor of the Journal of Vascular Surgery. In 2001 he developed and then served as Medical Director of the SVS Vascular Quality Initiative, which now includes over  700 hospitals that share clinical data to improve vascular healthcare. In 2016 he received the Society for Vascular Surgery Lifetime Achievement Award.   Alik Farber is Chief of the Division of Vascular and Endovascular Surgery at Boston Medical Center and Professor of Surgery and Radiology at Boston University School of Medicine.  Dr. Farber obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital, a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center and an endovascular surgery fellowship at the Southern Illinois School of Medicine.  Dr. Farber is currently a National Co-Chair of the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial.   Erica Mitchell is a board certified Vascular and Endovascular Surgeon with additional fellowship training in Interventional Radiology. She received her medical degree from the University of Colorado and completed general surgery residency and interventional radiology training at the University of Colorado Health Science Center. She completed her vascular surgery fellowship at Oregon Health & Science University where she served as Professor of Surgery, Program Director for Vascular Surgery, and Vice- Chair for Quality for the Department of Surgery until 2018. Dr. Mitchell practices vascular and endovascular surgery while currently enrolled in a Master of Health care and Delivery program at Dartmouth College. She enthusiastically supports surgical resident wellness and is the Founder of the virtual platform The Doc Pod, that provides a forum for confidential peer support.  As of the new year, she will be transitioning to Memphis, Tennessee, where she will be Professor Surgery, University of Tennessee, and Medical Director for Vascular and Endovascular Surgery at Regional One Hospital in Memphis Link to sample application chapter on endoleak management: https://zingtree.com/host-gallery.php?gallery_id=180&persist_names=Restart&persist_node_ids=45   Link to Sample chapters via Amazon.com  (click the “look inside” button) https://www.amazon.com/Vascular-Decision-Making-Jack-Cronenewett/dp/1975115813 If you enjoy our content, please contribute to Support Audible Bleeding.  Help us improve through our Listener Survey. Follow us on Twitter: @AudibleBleeding    

October 28, 2020 Why a Career in Vascular Surgery with Dr. Bernadette Aulivola   In partnership with Behind the Knife and the Association of Program Directors in Vascular Surgery   Episode Notes   Today, we have the first in a two-part series of episodes that we are developing in conjunction with the Association of Program Directors in Vascular Surgery and the Behind the Knife podcast on the reasons why one should pursue a career in Vascular Surgery Dr. Bernadette Aulivola is a Professor of Vascular Surgery and Endovascular Surgery and the Division Director of Vascular Surgery at Loyola University Medical Center Vascular Surgeon: Bernadette Aulivola, MD, FACS   Check out Behind the Knife here: Behind the Knife: Home or on any podcast platform. Find a Vascular mentor here: Mentor Match Program   If you enjoy our content, please contribute to Support Audible Bleeding!   Tell us about yourself through our Listener Survey!

Dr. Bernadette Aulivola is a Professor of Vascular Surgery and Endovascular Surgery at Loyola Medical Center and the Division Director of Vascular Surgery.  https://loyolamedicine.org/doctor/bernadette-aulivola Check out Audible Bleeding here https://www.audiblebleeding.com/ or on any podcast platform.  Find a vascular mentor here! https://svsconnect.vascular.org/home Request Dr. Aulivola and Dr. Ellozy  

Dr. Hazim J. Safi earned his medical degree at the University of Baghdad and completed his general surgery internship at Medical City Teaching Hospital in Baghdad and St. James Hospital in London, England. He completed his general surgery followed by his cardiothoracic residency at Baylor College of Medicine in Houston, studying under Dr. Michael DeBakey and Dr. Stanley Crawford. Dr. Safi is a professor and the founding chairman of the department of Cardiothoracic and Vascular Surgery at McGovern Medical School at UTHealth in Houston and chief of cardiothoracic and vascular surgery at Memorial Hermann Heart & Vascular Institute. Throughout his almost 50 year career, he has co-authored 30 book chapters and 200 scientific articles, and he is credited with the innovation and development of internationally recognized surgical techniques that have dramatically improved patient outcomes in aortic surgery.    Dr. Bruce Tjaden Jr earned a Bachelor of Arts degree from Boston University and attended medical school at the University of Kansas. He then completed his surgery residency at the Department of Surgery at the University of Kansas Hospital, and a vascular surgery fellowship at the University of Texas – Houston Health Science Center / Memorial Hermann Hospital under Dr. Hazim Safi and Dr. Ali Azizzadeh. Dr. Tjaden then joined Dr. Safi’s Department of Cardiothoracic and Vascular Surgery and practiced as an academic vascular surgeon at Memorial Hermann as well as surrounding Houston hospitals. He is now an Assistant Professor of Vascular and Endovascular Surgery at Cooper University Hospital in Camden, New Jersey and he has a particular interest in the management of aortic dissection and thoracic endovascular aortic repair. A Time for All Things: The Life of Michael E. Debakey https://www.amazon.com/Time-All-Things-Michael-DeBakey/dp/0190073942 If you enjoy our content, please contribute to Support Audible Bleeding.  Help us improve through our Listener Survey. Follow us on Twitter: @AudibleBleeding      

Dr. Ross Naylor (MBChB MD FRCS) is Professor of Vascular Surgery at the Leicester Vascular Institute, Leicester UK. He is a past President of the Vascular Society of Great Britain and Ireland and a past Editor in Chief of the European Journal of Vascular and Endovascular Surgery. He has authored 600 publications and book chapters, co-edited three textbooks of Vascular Surgery and his work has been cited over 17,000 times. He has just recently retired from clinical practice and we were lucky enough to interview him about his career and insights in carotid surgery. If you enjoy our content, please contribute to Support Audible Bleeding! Tell us about yourself through our Listener Survey!  

July 26th, 2020   Representation Matters: Recruitment and Retention of URM to Vascular Surgery In this second episode from our series on race and representation in medicine, we focus on the challenges of recruitment and retention of racial and ethnic minority groups that are underrepresented in medicine (URM) to vascular surgery. We are very pleased to have with us a number of guests at different levels of training to discuss their experiences and insights.   Dr. Chelsea Dorsey is faculty in the Section of Vascular Surgery at the University of Chicago and serves as the Director of the UChicago Vein Clinic and Ambulatory Medical Director for Cardiac, Vascular, and Thoracic Surgery.  She is a graduate of the Pritzker School of Medicine, where she developed an interest in health care inequalities. In addition, she volunteered her time helping pipeline programs and outreach activities in the community geared toward increasing the number of underrepresented minorities in the medical field.  After completing her Vascular Surgery training at Stanford University as the first woman and first African American accepted into the training program, she returned as faculty at the University of Chicago Medicine.  She serves as Director of Preclinical Advising in the medical school. She has served on the BSD Faculty Diversity Committee since 2017 and was recently appointed Chair of the Diversity, Equity, and Inclusion Steering Committee in the Department of Surgery.     Dr. Elsie Ross is a vascular surgeon and research scientist in the Division of Vascular Surgery at Stanford University. She graduated from Stanford University School of Medicine in 2011 and completed her vascular surgery integrated residency at Stanford University School of Medicine in 2018. During her residency, she completed a two-year post-doctoral fellowship in biomedical informatics. Her current research focuses on using machine learning and electronic health records for early disease identification, precision medicine, and evaluating opportunities to engage in patient education beyond the clinic. She is a Fulbright Scholar and a Soros Fellow, and is a recipient of the Young Investigators Award from the Association for Academic Surgery, as well as the Junior Faculty Award from the Society of University Surgeons.   Dr.  Joel L. Ramirez, MD, is the inaugural UCSF Integrated Vascular Surgery resident. He completed his undergraduate education at the University of California, Irvine, and  received his medical degree from the UCSF School of Medicine, graduating with Distinction in Clinical and Translation Research, and as a member of Alpha Omega Alpha. Dr. Ramirez conducted an NIH-funded pre-doctoral research fellowship between his third and fourth years of medical school with the UCSF Division of Vascular and Endovascular Surgery. In 2018, he was awarded first place for the Western Vascular Society Robert Hye Memorial Best Resident Presentation Award, for his research reporting on long term outcomes of endovascular aortic aneurysm repair. Dr. Ramirez has been the recipient of numerous other research fellowships, awards, and honors, including the American Medical Association Foundation Physicians of Tomorrow Award, the Society for Vascular Surgery Foundation Student Research Fellowship for two consecutive years, the American Heart Association Student Scholarship in Cardiovascular Disease, and the Association for Academic Surgery Senior Medical Student Award, among many others.   Dr. Ronald Dalman is the Walter C. and Elsa R. Chidester Professor and Chief of Vascular Surgery at Stanford University. He is also the current President of the Society for Vascular Surgery. Dr. Dalman earned his medical degree at the University of Michigan and completed surgical training at the University of Washington (Seattle) and his vascular fellowship at the Oregon Health and Sciences University. Dr. Dalman joined Stanford directly out of training and has led the vascular program since 2005. He is a member of the Vascular Surgery Board, American Board of Surgery, and a past member of the Residency Review Committee for Surgery, ACGME. At Stanford Health Care he serves as Co-Director and Chief Quality Officer for the Cardiovascular Service Line. At the School of Medicine, Dr. Dalman is a Steering Committee and founding member of the Cardiovascular Institute (CVI). Dr. Dalman's research laboratory studies the pathophysiology of abdominal aortic aneurysm (AAA) disease, and is actively engaged in identifying and validating new treatment measures for AAA.    Additional Resources:   Dr. Dorsey’s presentation from the VESS paper session at the SVSOnline-  Update on Workforce Diversity in Vascular Surgery: What has changed in 20 years? https://cdmcd.co/RqbR89    Perceptual and Structural Facilitators and Barriers to Becoming a Surgeon: A Qualitative Study of African-American and Latino Surgeons Ulloa et al. Acad Med. 2018 September ; 93(9): 1326–1334. doi:10.1097/ACM.0000000000002282 https://pubmed.ncbi.nlm.nih.gov/29742613/   Structural Solutions for the Rarest of the Rare: Underrepresented-Minority Faculty in Medical Subspecialties Kemi M. Doll, M.D., and Charles R. Thomas, Jr., M.D. N Engl J Med 2020; 383:283-285 DOI: 10.1056/NEJMms2003544   If you enjoy our content, please contribute to Support Audible Bleeding.   Help us improve through our Listener Survey.   Follow us on Twitter: @AudibleBleeding  

June 22nd, 2020 Race and Representation in Medicine: Addressing Implicit Bias in the Workplace In light of the events unfolding across the country over the past few weeks, The Society for Vascular Surgery's  Diversity Equity and Inclusion Task Force and the Wellness Task Force sponsored a webinar around race in America and its impact on our field. We at Audible Bleeding thought this was an excellent start, and we would hope to keep the conversation going. As such, this will be the first in a series of episodes on race and representation in medicine. Today we would like to discuss the challenges of addressing implicit bias in the workplace. We are very pleased to have with us a number of guests at different levels of training to discuss their experiences and insights. Dr. Vincent Rowe is a Professor of Surgery at the Keck School of Medicine of USC. He is the Program Director of the Vascular Surgery Residency. He earned his medical degree from the University of Southern California School of Medicine, and trained in general surgery at Kaiser Permanente Medical Center in Los Angeles. He subsequently completed a two-year Vascular Surgery Fellowship at the University of Tennessee Medical Center in Knoxville Tennessee. Dr. Olamide Alabi is an Assistant Professor of Surgery in the Division of Vascular Surgery and Endovascular Therapy at the Emory University School of Medicine. She received her medical degree from the University of Nebraska College of Medicine, trained in general surgery at Loma Linda University Medical Center in Southern California, and completed a fellowship in Vascular Surgery at Oregon Health and Science University. Dr. Nina Bowens is an Assistant Professor in Surgery, UCLA School of Medicine, and a member of the Division of Vascular and Endovascular Surgery at Harbor-UCLA. She earned her medical degree at Weill Cornell Medical College and trained in general surgery at the University of Pennsylvania. She completed her Vascular Surgery fellowship at the New York Presbyterian Hospital.   Dr. Osarumen Okunbor is a graduate of Meharry Medical College, completed his General surgery at Louisiana State University in New Orleans, and will be starting his Vascular Surgery fellowship at University of Washington in Seattle.    If you enjoy our content, please contribute to Support Audible Bleeding. Help us improve through our Listener Survey. Follow us on Twitter: @AudibleBleeding

DuBose and Dr. Ravi Rajani, Chief of Vascular and Endovascular Surgery at Atlanta's Grady Memorial Hospital and Associate Professor at Emory University, discuss the approach to the patient with extremity injury and how to pick up on indications of vascular injury. Talking points include why there is no such thing as a Doppler pulse, and how we tend to ignore the first word in the name "pulse oximeter." Ravi finishes up by being correctly indignant that we are expected to wash dishes before putting them into a dishwasher. It doesn't make any sense, people. 

In episode four of Open Up, Jess speaks with Dr. Matt Menard (Co-Director, Endovascular Surgery/Program Director, Vascular and Endovascular Surgical Fellowship/Assistant Professor, Harvard Medical School Vascular and Endovascular Surgery) about his winding path toward surgical medicine and the long term process of creating a cross departmental cardiovascular trial from idea to dissemination.  Dr. Menard discusses what makes the patient and surgeon relationship unique and the importance of removing departmental silos in an effort to generate productive research. He also expresses the need for community investment in research to ensure longevity and statistical significance for long term projects.  Quote of the Episode:  “I think science is our best honest effort to get to the truth” -Dr. Matt Menard

Dr. Stephan Haulon is Professor of Vascular Surgery, and Chair of Aortic and Vascular Surgery at the Hospital Marie Lannelongue, Groupe Hospitalier Paris Saint Joseph, Université Paris Saclay. He serves as the current president of the European Society for Vascular Surgery. He completed his general surgical and vascular training at the University of Lille in France and then went on to do a Vascular Surgery Research Fellowship at the Cleveland Clinic under the mentorship of aortic pioneer Dr. Roy Greenberg and funded by a Marco Polo Grant from the ESVS and SVS. Throughout his career he has worked closely with colleagues in Cardiac Surgery, Interventional Radiology, and Vascular Medicine and is a strong proponent of international and interdisciplinary collaboration.  Dr. Robert Rhee is a returning guest to the podcast. He is a Clinical Professor of Surgery at SUNY Downstate Medical College and the Director of Vascular and Endovascular Surgery at Maimonides Medical Center in Brooklyn. He is the President-Elect of the Eastern Vascular Society and the Program Director for the Vascular Surgery Fellowship at Maimonides hospital.  Our guests join us today to discuss how their departments have adapted during the current COVID-19 pandemic and how we begin to look ahead. Paris and New York City, both densely populated and internationally connected, were similarly hit hard in terms of the volume of COVID-19 cases and the extreme strain placed on healthcare systems. As the pandemic struck Paris a few weeks before New York City, Dr. Haulon is able to give us some insight into the process of transitioning to a new normal. He also discusses the future of medical meetings, and what he is excited about on the horizon for vascular surgery. If you enjoy our content, please contribute to Support Audible Bleeding! Tell us about yourself through our Listener Survey!

April 9th, 2020   Update from New York City: Lessons learned from the first weeks of the COVID-19 pandemic   As part of our ongoing series of COVID-19 related episodes, we interview several New York City vascular surgeons to see what lessons can be gleaned from their experiences during the first few weeks of the pandemic. We discuss such topics as call coverage, redeployment, setting up a line service, and protecting ourselves from infection while caring for the COVID-19 patient. We also get some insight into how to take care of our own well-being, and what people have found uplifting during these difficult times.    Dr. Daniel Han is an Associate Professor of Surgery at the Icahn School of Medicine at Mount Sinai, associate program director of the integrated vascular residency, and Co-Director of the Surgery Clerkship. He is active in numerous vascular societies, and is an assistant editor of the Journal of Vascular Surgery.   Dr. Evan Lipsitz is Professor of Vascular Surgery in the Department of Cardiovascular & Thoracic Surgery and Chief of the Division of Vascular and Endovascular Surgery at the Montefiore Medical Center and Albert Einstein College of Medicine in the Bronx. He is Medical Director of the Vascular Laboratory there as well. Dr. Robert Rhee is a Clinical Professor of Surgery at SUNY Downstate Medical College and the Director of Vascular and Endovascular Surgery at Maimonides Medical Center in Brooklyn. He is also the Program Director for the Vascular Surgery Fellowship at Maimonides hospital   Dr. Darren Schneider is Chief of Vascular and Endovascular Surgery at NewYork Presbyterian Hospital/Weill Cornell Medical Center and is a returning guest on the podcast.  Episode 12 -Paclitaxel-Coated Balloons and Stents - Increased mortality or statistical anomaly? If you enjoy our content, please contribute to Support Audible Bleeding!   Tell us about yourself through our Listener Survey!  

3/27/20    Impact of COVID19 on resident and fellow education   In this special episode of Audible Bleeding, we explore the impact of the COVID-19 pandemic on the education of vascular trainees with Dr. Jason Lee, Dr. Chris Abularrage, and Dr. Lori Pounds. We discuss challenges, including the precipitous drop in case volume, protecting staff, managing call coverage and clinical responsibilities, and didactic education in the face of social distancing. We also discuss educational opportunities that this crisis presents, including crowdsourcing and sharing of educational resources across departments.     Dr. Jason Lee is a Professor of Surgery, the Director of Endovascular Surgery, and the Vascular Surgery Residency and Fellowship Program Director at Stanford University Medical Center. He is also the Secretary and Treasurer of the Association of Program Directors in Vascular Surgery   Dr. Chris Abularrage is an Associate Professor of Surgery Director of the Diabetic Foot and Wound Clinic and Vascular Surgery Fellowship Program Director at The Johns Hopkins Department of Surgery. He is also Chair of the Curriculum committee of the Association of Program Directors in Vascular Surgery and Editor-in-Chief of VSCORE for the American Board of Surgery.    Dr. Lori Pounds is a Professor of Vascular Surgery and Vascular Surgery Fellowship Program Director at UT Health San Antonio, as well as Chief of Vascular Surgery at the San Antonio VA. She is also Chair of the Education Committee of the Association of Program Directors in Vascular Surgery.  If you enjoy our content, please contribute to Support Audible Bleeding!   Tell us about yourself through our Audible Bleeding Listener Survey!   

In this special episode of Audible Bleeding, we sit down (socially distanced by miles) with Drs. Ben Starnes, Niten Singh and Malachi Sheahan to discuss how we as vascular surgeons should be approaching our practices and our roles within the hospital throughout this COVID-19 pandemic.  Dr. Starnes and Dr. Singh recently authored an editorial in Vascular Specialist describing their experience with the COVID-19 virus, as well as some of the changes they have made in their service line based on insight they gained from vascular surgery colleagues in Northern Italy. We are also fortunate to have Dr. Malachi Sheahan on the podcast with us to discuss some of the lessons he learned during his time at University Hospital in New Orleans after Hurricane Katrina, and how that can help us going forward.    Dr. Starnes is a returning guest at Audible bleeding and I encourage you to listen to Episode 11 for a complete intro and to hear the discussion on his military experience and entrepreneurial endeavors.  Dr Starnes is a Professor of Vascular Surgery, Chief of the Division of Vascular Surgery and Vice Chair of the Department of Surgery for UW Medicine.    Dr. Niten Singh is a Professor and Associate Chief of the Division of Vascular Surgery at University of Washington.  He’s also the Director of the Limb Preservation Service at the Regional Vascular Center at Harborview and the Program Director of the UW Vascular Surgery Integrated Residency and Fellowship. Dr. Singh earned his M.D. from the Uniformed Services University of the Health Sciences in Bethesda, Maryland.  He completed his general surgery residency at Tripler Army Medical Center in Honolulu, HI and his Vascular surgery fellowship at Georgetown in Washington DC.   Dr. Malachi Sheahan is also a returning guest on Audible Bleeding and I would likewise encourage you to go back and listen to Episode 3 for a discussion on mentorship, the Fundamentals of Vascular Surgery curriculum and vascular surgery during Hurricane Katrina.  Dr. Sheahan is Professor and Chair of Vascular and Endovascular Surgery and Program Director for the Vascular Surgery Integrated Residency and Fellowship at LSU Health Sciences Center in New Orleans   Links:   Letter From Seattle (Dr. Starnes’ and Dr. Singh’s editorial in Vascular Specialist)   SVS Connect   The SurgeonMasters Podcast  

Audible Bleeding sits down with Drs. Malachi Sheahan, Dawn Coleman and John Eidt to discuss the SVS Wellness Task Force and peer support.   Dr. Malachi Sheahan is a returning guest on Audible Bleeding. He was featured on our 3rd episode discussing the Fundamentals of Vascular and Endovascular Surgery curriculum and his experience as a surgeon during Hurricane Katrina.  Dr. Sheahan is a Professor and Chair of Vascular and Endovascular Surgery and Program Director for the Vascular Surgery Integrated Residency and Fellowship at the LSU Health Sciences Center in New Orleans. Dr. Dawn Coleman is also a returning guest.  She spoke with us on physician burnout in episode 20.  She is an Associate Professor of Surgery at the University of Michigan, and she is the Program Director of the Integrated Vascular Surgery Residency Program and Fellowship.  She is the Chair of the SVS Wellness Task Force and discusses the results of the vascular surgery burnout survey on today’s podcast.   Dr. John Eidt is a practicing vascular surgeon at Baylor Scott and White Heart and Vascular Institute and a Professor of Surgery at Texas A&M Health Sciences and the Vice Chair of Surgery at Baylor University Medical center.  He has an interest in surgical education and surgeon well-being. Dr. Sheahan’s Editorial: “Am I my brother's keeper?” https://vascular.org/news-advocacy/editor-am-i-my-brothers-keeper-skeptics-call-peer-support-vascular-surgery Surgeon Masters Podcast: https://surgeonmasters.com/podcast SVS Connect https://svsconnect.vascular.org/home Stay on the lookout for the upcoming Webinar and live call with Surgeon Masters on March 4th, 2020! Further details to follow.   If you enjoy our content, please contribute to Support Audible Bleeding! Tell us about yourself through our Listener Survey!  

Best Endovascular vs. best Surgical Therapy in patients with Critical Limb Ischemia (BEST-CLI) is a prospective, multicenter, randomized, open-label (two-arm), comparison to evaluate the effectiveness of best surgical to best endovascular revascularization in patients with CLI. Dr. Alik Farber is a Professor of Surgery and Radiology at Boston University School of Medicine and the Chief of Vascular and Endovascular Surgery at Boston Medical Center. Dr. Matthew Menard is an Associate Professor of Surgery at Harvard Medical School and is Co-Director of Endovascular Surgery and Program Director of the vascular surgery fellowship at Brigham and Women’s Hospital. Topics Discussed History of the trial - mentors involved, interactions with the NIH Context of the literature - limitations of the BASIL trial Barriers to enrollment and strategies of successful institutions Choosing the endpoint of Major Adverse Limb Event (Male)-free survival Implications of cost-effectiveness component Impact of paclitaxel controversy on the trial Early lessons learned and much, much, more!! Register here for the Big Apple Bootcamp Support Audible Bleeding Here!

Dr. Michael Conte is a professor of surgery and co director of the UCSF Heart and Vascular center and chief of the division of Vascular and Endovascular Surgery. Dr. Conte is the lead author on the Global vascular guidelines on the management of chronic limb-threatening ischemia just published in the Journal of Vascular Surgery in June 2019.   Article link https://www.jvascsurg.org/article/S0741-5214(19)30321-0/fulltext   To access the SVS that includes WIFI Calculator search in iTunes Store or Google Play for "SVS iPG". It is free and full of useful information and calculators to use in everyday practice.  

Episode 1 of 3 from our time at VAM 2019 Dr. Joseph Lombardi is a Professor of Surgery at Cooper Medical School and Head of The Division of Vascular and Endovascular Surgery at Cooper University. He is the PI of the Stable II Trial on endovascular treatment of Acute, Complicated Type B Aortic Dissection with a Composite graft design.    Stable I Trial https://www.ncbi.nlm.nih.gov/pubmed/22169668 Stable II Trial https://www.jvascsurg.org/article/S0741-5214(16)00633-9/fulltext    SVS/STS Dissection Classification System Please see Audible Bleeding’s Twitter feed for an animation of the new classification system.   To Support Audible Bleeding please go to Audiblebleeding.com/support

Audible Bleeding is excited to announce our new collaboration with the Journal of Vascular Surgery. We aim to present high impact articles in a digestible audio format and provide insights into their broader context and how the research developed through interviews with the journal editors and highlighted authors. Our guests on this episode are Journal of Vascular Surgery Editors, Dr. Peter Gloviczki and Dr. Peter Lawrence to introduce this collaboration and discuss their session at the upcoming #VAM19. B4: CRITICAL ISSUES FOR AUTHORS AND REVIEWERS A joint session of JVS/EJVES/JAMA Surgery Friday, June 14, 2019 6:30 - 8:00 am Dr. Peter Gloviczki is the Editor-in-Chief of the Journal of Vascular Surgery.  He completed his general surgery and vascular training at Semmelweis University in Budapest, Hungary, at St. Michel and St. Joseph Hospitals in Paris, France, and at the Mayo Clinic in Rochester, MN, where he joined faculty and then became Chair of the Division of Vascular and Endovascular Surgery from 2000-2010.  He is a Past President of the SVS and WFVS, as well as numerous other national and regional vascular societies. He has over 400 peer-reviewed publications, and he has edited seven textbooks, including multiple editions of Rutherford’s Vascular Surgery.  Dr. Peter Lawrence is the Senior Editor of the Journal of Vascular Surgery.  He completed his general surgery and vascular training at Columbia-Presbyterian Medical Center in New York, spent his early career at the University of Utah but now serves as the Chief of Vascular Surgery and the Bergman Chair in Vascular Research at University of California Los Angeles. He is a Past President of the SVS and SVS Foundation.  Dr. Lawrence is committed to medical education as seen by his involvement in the National Board of Medical Examiners and the American Boards of Surgery and Vascular Surgery. He has served on the editorial board or as a selected reviewer for eleven medical journals.  Support Audible Bleeding!

Dr. Warren Gasper is the Chief of Vascular Surgery at the San Francisco VA, an assistant professor of vascular surgery at UCSF, and the president of the Northern California Vascular Society. He did his general surgery residency and vascular surgery fellowship at UCSF. He is the principal investigator in multiple NIH-funded clinical trials studying interventions for PAD, broadening the application of MRA imaging in vascular surgery, and treatment of para-visceral and thoracic aortic aneurysms with fenestrated endografts. Dr. Ahmed Shalabi (Ahmed.Shalabi@ucsf.edu, LinkedIn) is the Chief of Vascular Anesthesia at UCSF, where he is an associate professor of anesthesia and perioperative care. He did his residency in anesthesia at the Alexandria University Hospital in Egypt and has pursued advanced training in pediatric anesthesia at the University of Lille in France, in transplantation anesthesia at UCSF, and in transesophageal echocardiography at UCLA. He discovered his passion for doing anesthesia for complex open and endovascular cases and is a member of the Center for Aortic Excellence at UCSF, where he has developed a Vascular Anesthesia Quality Improvement Database. Dr. Leigh Ann O'Banion (lobanion@fresno.ucsf.edu) is an assistant professor of Vascular Surgery at UCSF Fresno, where she also completed her general surgery residency. She did her fellowship in vascular surgery at UCSF, graduated in 2017 and then returned to UCSF Fresno as an attending. She has a busy clinical practice with a focus on mentoring the next generation of vascular trainees. She is currently enrolling patients in a prospective study focused on improving the multidisciplinary system of care for patients who undergo amputations. Anesthesia in acute aortic syndrome: Review Article: Anesthesia for vascular emergencies. Ellard L and Djaiani G. Anaesthesia. 68 (Suppl. 1), 72-83. 2013 Outcomes for EVAR under sedation / local: Observations from the IMPROVE trial concerning the clinical care of patients with ruptured abdominal aortic aneurysm. IMPROVE trial investigators. British Journal of Surgery. 101(3): 216-224. 2014 Decreased mortality with local versus general anesthesia in endovascular aneurysm repair for ruptured abdominal aortic aneurysm in the Vascular Quality Initiative database. Faizer R et al. Journal of Vascular Surgery. S0741-5214(18)32551-5. 2019 Local anesthesia for percutaneous endovascular abdominal aneurysm repair is associated with fewer pulmonary complications. Van Orden K et. al. Journal of Vascular Surgery. 68(4) 1023-1029. 2018 Type of Anesthesia for Endovascular Abdominal Aortic Aneurysm Repair. Armstrong RA et. al. Journal of Cardiothoracic and Vascular Anesthesia. 33: 462-471. 2019 Renoprotection: Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine. Weisbord SD et. al. New England Journal of Medicine. 378(7): 603-614. 2018 Mannitol for the Prevention of Peri-Operative Acute Kidney Injury: Systematic Review. Waskowski J et. al. European Journal of Vascular and Endovascular Surgery. In press. 2019 Spinal cord protection guidelines for thoracic aortic work: 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease. Hiratzka LF et. al. Circulation. 121(13): e266-369. 2010 Contemporary spinal cord protection during thoracic and thoracoabdominal aortic surgery and endovascular aortic repair: a position paper of the vascular domain of the European Association for Cardio-Thoracic Surgery. Etz CD et. al. European Journal of Cardio-Thoracic Surgery. 47: 943-957. 2015 Perioperative coronary artery revascularization and antiplatelet bridging: Coronary-Artery Revascularization before Elective Major Vascular Surgery. McFalls EO et. al. New England Journal of Medicine. 351(27) 2795-804. 2004 Bridging antiplatelet therapy with cangrelor in patients with recent intracranial stenting undergoing invasive procedures: a prospective case series. Godier A. British Journal of Anaesthesia. In press. 2019 Rapid ventricular pacing for aortic arch work: Rapid Ventricular Pacing for Landing Zone Precision During Thoracic Endovascular Aortic Arch Repair: A Case Series. Bokoch MP et. al. Journal of Cardiothoracic and Vascular Anesthesia. 31: 2141-2146. 2017

Dr. Steve Elias speaks with Dr. Angela A. Kokkosis and Dr. Pamela S. Kim, both of whom work at Stony Brook Medicine, Division of Vascular and Endovascular Surgery, to see what some of the younger members of the vein community have to say about the ever-evolving world of veins.

  To support our podcast, please visit: https://www.audiblebleeding.com/support/ Dr. David Rigberg is a clinical professor of surgery in the Division of Vascular and Endovascular Surgery at the UCLA David Geffen School of Medicine and the Program Director for the Vascular Surgery Integrated Residency and Fellowship at UCLA. He is the president of the Southern California Vascular Surgical Society as well as the chair of the SVS Resident and Student Outreach Committee. He serves on faculty for the Medical Student and Resident Simulation Program at the VAM and the annual Cardiovascular Fellows Boot Camp in Houston. He joins us to discuss career development and education in vascular surgery, the satisfaction he gets from his venous work, and the role music plays in his life. Career development & training: Introduction to Academic Vascular Surgery SVS Vascular Annual Meeting Dr. Malachi Sheahan’s Fundamentals of Vascular Surgery Houston Methodist Cardiovascular Fellows Bootcamp Cardiovascular Fellows Bootcamp - YouTube channel Pacific Northwest Endovascular Course Vascular Surgery workforce Recruitment for vascular disease management struggles to keep up with expected demands on the workforce  Operative tips & tricks Balloon Control of the Suprahepatic Inferior Vena Cava: A Novel Technique for Renal Cell Carcinoma Tumor Thrombus Tips and Tricks: Dealing with a troublesome peritoneal dialysis catheter